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ABSTRACT
Anxiety is the most prevalent mental illness and treatments are effective but
underutilized. Failure to design treatments that proactively reach individuals at varying
levels of readiness may be one driver of under-utilization. The Transtheoretical Model
of behavior change (TTM) offers a framework for designing treatments tailored to
readiness to engage in exposure, the process of gradually approaching feared stimuli
and the central behavioral component of evidence-based anxiety treatments. This
study sought to develop the essential building blocks for applying the TTM to anxiety
by developing a set of measures of core TTM constructs (Stage of Change, Decisional
Balance, Self-efficacy, and Processes of Change) relevant for increasing approach
behaviors in individuals with anxiety disorders.
Measurement development entailed qualitative methods for item development and
refinement followed by a series of quantitative analyses. The Stage of Change measure
was validated against external constructs such as treatment seeking behavior, anxiety
severity, and quality of life. As expected, a chi-square test indicated that individuals in
Action and Maintenance were significantly more likely to be in treatment than those in
the pre-Action stages. ANOVA results indicated that individuals in Action or
Maintenance reported significantly lower levels of anxiety (F(1, 592) = 5.06, p=.025,
η2=.01) and significantly higher quality of life (F(1, 592) = 8.20, p<.01, η2=.01) than
those in pre-Action stages.
Measures for Decisional Balance and Self-efficacy were developed using splithalf, cross-validation procedures. In these, a series of Principle Component Analyses
(PCAs) were conducted with half of the sample to narrow the item set and explore

factor structure, and Confirmatory Factor Analyses (CFA) was conducted on the
second half of the sample to confirm factor structure and item loadings. For
Decisional Balance, PCA supported two, 5-item factors, and CFA indicated a twofactor correlated model was the best fit to the data, χ²(35)=80.82, p<.01, CFI=.94,
RMSEA =.7 with Pros α=.87 and Cons α=.75. For Self-efficacy, PCA supported one,
6-item factor, and CFA further supported this structure, χ²(9)=30.39, p<.01, CFI=.98,
RMSEA=.088, α=.90. Multivariate analyses indicated significant stage-construct
relationships in expected directions with the exception of Cons, which showed no
significant cross-Stage differences.
For Processes of Change, a series of iterative CFAs were conducted to narrow the
item set, and then additional CFAs were conducted on the final set of items to
determine which factor structure was the best fit to the data. A 10-factor, fully
correlated model was the best fit to the data, χ²(360)=905.82, p<.01, CFI=.94, RMSEA
=.51. Factor loadings were strong, ranging from 0.53 to 0.85, and internal consistency
was acceptable to good (α ranged from to .69 to .88). Effect sizes for differences in
POC across Stage were mostly in the medium range, indicating that POC represent
important behavior change strategies for reducing anxiety-based avoidance.
Overall results support the validity of the measures developed and laid the
foundation for applying the TTM to anxiety-based avoidance. Implications for
application of the TTM to anxiety-based avoidance are discussed. Future research
should explore the relationship between these measures and treatment outcomes
longitudinally and examine the effectiveness of TTM-tailored feedback in the context
of a computer-based intervention.

ACKNOWLEDGMENTS
I would like to express my gratitude to my major professor, Dr. James Prochaska,
for inviting me to join his research lab and mentoring me for the last five and a half
years. His guidance, patience, and enthusiasm for my intellectual development have
been invaluable. I am also grateful to the many of the faculty at the University of
Rhode Island and Brown University who have supported this work and my
development as an independent clinician and researcher: Colleen Redding, Andrea
Paiva, Deborah Levesque, Joe Rossi, Risa Weisberg, Kristy Dalrymple, Bryan
Blissmer, Ginette Ferszt, Wayne Velicer, and Ellen Flannery Schroeder. Furthermore,
generous advice from several other graduate students, Leslie Brick, Steve Babbin,
Annie Farlie, Michael Bernstein, and Cerissa Blaney, was hugely helpful in allowing
me navigate the methodological and logistical issues I had in completing this
dissertation. I look forward to future collaborations with them. Additionally, I want to
mention several of my early mentors, John Wincze, Shirley Yen, Ronald Seifer and
Brian Hayden, who infected me with their enthusiasm for clinical psychology and
academic inquiry and encouraged me to pursue a doctorate degree. Perhaps most
importantly, I could not have done any of this without my loving parents, my two
brilliant and caring sisters, and a small tribe of friends who offered unwavering moral
support and constant light relief.

iv

PREFACE
This dissertation was prepared in manuscript format. The three manuscripts
contained therein have been written with the intention of submission to the following
journals: Journal of Anxiety Disorders (Manuscript 1), American Journal of Health
Promotion (Manuscript 2), and Journal of Nervous and Mental Disease (Manuscript
3). The Appendix includes supplementary tables for the prepared manuscripts and
discussion of additional analyses and findings that did not fit into the scope of the
three primary manuscripts.
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Abstract
Anxiety is the most prevalent mental illness and treatments are effective but
underutilized. Failure to design treatments that proactively reach individuals at varying
levels of readiness may be one driver of under-utilization. The Transtheoretical Model
of behavior change (TTM) offers a framework for designing treatments tailored to
readiness to engage in exposure, a core behavioral component of anxiety treatment.
The purpose of this study was to develop a measure of Stage of Change, the core TTM
construct that defines readiness to change, relevant for anxiety-based avoidance.
Online survey data were collected from 594 adults with clinically significant levels of
anxiety. Survey data included measures of Stage of Change, anxiety severity, quality
of life and current treatment status. Findings support the validity of the Stage of
Change measure developed insofar as predicted relationships were observed between
Stage and anxiety severity, quality of life and treatment status.

Keywords
Stages of Change, Anxiety, Exposure, Readiness, Transtheoretical Model
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Anxiety is the most common form of mental health disorder, with lifetime
prevalence estimates as high as a quarter of the general population.1 Anxiety is
associated with significant impairments in educational and occupational functioning,
worse physical health, and huge public health cost (ranging from $42 to $46 billion
annually).2-5
Cognitive-Behavioral treatments (CBTs) for anxiety are effective but
underutilized. Effect sizes for CBTs for anxiety are large (d = 1.14 to 1.98)6,7 across
treatment protocols and by definition, do not produce the same risk of side effects seen
with pharmacological options. While protocols vary in a number of ways, exposure, or
the process of systematically approaching feared stimuli in a progressively more
emotionally challenging fashion, is a consistent part of CBTs for anxiety and arguably
a cornerstone of these treatments. Dismantling studies have even found that exposureonly therapies often perform as well as therapies with exposure plus additional
cognitive components.8 9
Unfortunately, only 4-11% of individuals with anxiety disorders receive any
treatment.10 Of those who do receive treatment, the majority receive pharmacotherapy.
Of those who receive psychotherapy, a minority are getting psychotherapy with CBT
techniques like exposure.2,11 While much of the dissemination research to date has
focused on increasing access, avoidance itself and perceived need are other prominent
barriers to seeking treatment.10-12 These findings suggest a need to package exposurebased treatments differently such that they can reach a wider segment of the
population of individuals with anxiety disorders.

3

At least two steps are necessary to enhance the reach of exposure-based
treatments for anxiety. First, empirically-supported interventions must be made more
accessible so that they can reach a larger share of the population with anxiety
disorders. Computerized interventions offer a low-cost treatment strategy, ideal for
placement in widely used medical settings. Second, proactive approaches to treatment
are needed to reach the segment of the population of individuals who are suffering
from anxiety disorders, but not yet willing to make behavior changes necessary to
manage their anxiety (i.e., address anxiety-based avoidance).
The Transtheoretical Model of Behavior Change (TTM)13 provides a
framework for developing interventions that could address issues related to both
access and readiness to change key problematic behaviors like avoidance. The central
organizing feature of the TTM is the five Stages of Change, which define an
individual’s progress in preparing for and adopting new behavior patterns. The stages
include three pre-Action stages: Precontemplation (not intending to make a change in
the foreseeable future), Contemplation (intending to make a change in the next 6
months), and Preparation (preparing to make a change in the next 30 days). There are
two Action stages: Action (currently engaging in behavior change) and Maintenance
(sustained behavior change for at least 6 months). Each stage of change is
characterized in relation to a standard for the Action stage, which defines what is
meant by successful change and therefore, is the driving characteristic of the staging
algorithm.
The TTM provides guidance on development of stage-matched interventions.
These have most often been delivered as computer-tailored interventions or CTIs.
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Such interventions are easy to access, cost-effective and applicable both to individuals
ready to engage in change and those not yet ready. TTM-based CTIs have been used
to intervene effectively on a wide array of behaviors from weight management to
depression to domestic violence14-16 and may be a useful framework for
conceptualizing and intervening on anxiety-based avoidance.
To date, applications of the TTM to anxiety have been limited. In particular, no
anxiety-specific staging algorithm has been developed. Several studies have utilized
the University of Rhode Island Change Assessment (URICA)17 Stage of Change
measure as a predictor of treatment outcomes in pharmacotherapy as well as of
engagement and outcomes in psychotherapy.18-20 While the URICA offers a strong
measure of readiness in some contexts, it poses two core problems. First, difficulty of
scoring and interpretation are a barrier to use. Second, the URICA leaves the target of
change vague, and evaluations of staging algorithms for other types of behavior
change indicate using a specific definition for the target of change is optimal.21
The purpose of this study was to develop and assess preliminary validity of a
Stage of Change algorithm for reducing anxiety-based avoidance – the primary
behavioral target of evidence-based treatments for anxiety. Measures of anxiety
severity, quality of life, and treatment seeking behavior were evaluated in relation to
Stage to examine the validity the Action criterion used to define this measure of Stage
of Change. A wealth of literature on empirically supported behavioral treatments for
anxiety has established a link between approach behaviors and anxiety
reduction/improved quality of life. It was, therefore, hypothesized that individuals in
Action and Maintenance (i.e., those who were regularly challenging themselves to
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approach anxiety-producing stimuli in their environments) would report lower
symptoms and impairment from anxiety and better quality of life. Additionally, we
hypothesized that those in Action and Maintenance would be more likely to report
being in treatment for their anxiety, as approach behaviors are a primary target of
psychotherapy for anxiety and medications have been found to reduce symptoms of
anxiety, such as avoidance.
1. Method
1.1 Participants
1.1.1 Recruitment
Participants needed to meet two eligibility criteria to participate in the study:
they needed to be over the age of 18 and to score an 8 or higher on the Overall
Anxiety Severity and Impairment Scale (OASIS), which has been found to indicate
clinically significant anxiety.22 Prior to conducting online survey data collection,
qualitative interviews were conducted with a small set of participants (n=10) to
evaluate clarity and face validity of the staging algorithm. Qualitative interview
participants were recruited through flyers placed at community centers, mental health
treatment centers, and universities. Flyers asked that interested participants call the
primary investigator, at which point they were consented to engage in a screening
questionnaire for eligibility (age and OASIS score). Twenty individuals called to
inquire about participation. Thirteen of these individuals were eligible to participate,
and ten chose to participate in qualitative interviews. Participants in the qualitative
interviews were reimbursed $20 for their participation.
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The sample for the online survey portion of the study was recruited through
Survey Sampling International (SSI), an online survey sampling company. Toward the
end of survey data collection, additional eligibility criteria—only non-white
participants (25 completes) and only pre-Action Stage of Change (128 completes)—
were included for the remaining recruitment process in order to ensure an adequately
diverse sample. All recruitment and human subjects procedures were approved by the
University of Rhode Island’s institutional review board.
1.1.2 Sample Characteristics
Ten individuals participated in qualitative interviews. The average age was
36.6 and the average OASIS score was 11.3. Three of the qualitative interview
participants were recruited from a local mental health treatment center, four were
recruited from a community support center, and three were recruited from the
University of Rhode Island community. Seven of the qualitative interview participants
were male and three were non-white.
SSI recruited 594 eligible adults to participate in the online survey portion of
this study (sample demographics are summarized in Table 1). The sample was
primarily female (69.4%, n=412), and ages ranged from 18 to 80 (M = 38.6, SD =
13.8). The majority of the sample was white (n=454, 76.4%), 12.8% were Black
(n=76), 3.7% were Asian (n=22), and 7.1% classified themselves as not fitting any of
these racial categories (n=42). Of the 594 participants, 14.1% were in
Precontemplation (n=84), 3.9% were in Contemplation (n=23), 20.7% were in
Preparation (n=123), 17.0% were in Action (n=101), and 44.3% were in Maintenance
(n=263). Self-reported diagnoses were as follows: Panic Disorder 44.9% (n=267),
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Agoraphobia 11.8% (n=70), Obsessive Compulsive Disorder 25.6% (n=152), Posttraumatic Stress Disorder 19.9% (n=118), Social Anxiety Disorder 45.1% (n=268),
Generalized Anxiety Disorder 52.5% (n=312), Specific Phobia 12.1% (n=72), Anxiety
Not Otherwise Specified 13.8% (n=82), diagnosed with “anxiety” but not specific
disorder 4.2% (n=25), never diagnosed with an anxiety disorder 5.2% (n=31).
Diagnoses were self-reported and individuals were asked to select all diagnoses that
they had been given so diagnostic categories reported are not mutually exclusive.
1.2 Measures
In addition to the measures described below, the survey administered included
measures of demographic characteristics, self-reported anxiety diagnoses and current
treatment status. In terms of treatment status, individuals were asked to select one of
the following treatment status categories: (a) I am NOT currently in treatment for
anxiety; (b) I currently take medication for anxiety (prescribed by a health
professional like a doctor, nurse or psychiatrist); (c) I currently go to therapy or
counseling for anxiety (meeting for 30 minutes to an hour to discuss your feelings
with a professional); (d) I currently take medication and go to therapy for anxiety.
1.2.1 Overall Anxiety Severity and Impairment Scale (OASIS)23
The OASIS was used to determine eligibility for participation. The OASIS is a
5-item self-report measure that evaluates the severity of and impairment associated
with an anxiety disorder. Participants rate the degree to which each item describes
them over the past week on a 5-point scale ranging from 0 (None) to 4 (Extreme/All
the Time). A sum score of 8 or greater has been found to accurately classify 87% of
individuals as having an anxiety diagnosis.22 This scale was selected because of its
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strong psychometric properties, adequate coverage of symptoms relevant for all
anxiety diagnoses, and ease of use (i.e., short length, free access, and easy scoring).
1.2.2. Quality of Life Enjoyment and Satisfaction Questionnaire – Short Form (QLSEQ-SF)24
The Q-LES-Q-SF is designed to assess the level of enjoyment and satisfaction
individuals experience in activities of daily functioning. It is comprised of 14 items
evaluating satisfaction in a number of realms and two additional overall life
satisfaction items that are not included in the score for the measure. Participants rate
items on a 5-point scale ranging from 1 (Very Poor) to 5 (Very Good). A summary
score is calculated for the first 14-items and then converted to a proportion of the
maximum possible score. Higher proportions, therefore, indicate greater satisfaction
with life. This scale shows strong reliability and validity and, in particular, has shown
adequate sensitivity to the severity of anxiety.25,26
1.2.3. Stage of Change
Participants were asked to answer a series of questions about whether they
regularly challenge their tendency to avoid anxiety-producing stimuli (see appendix
for a printed copy of the measure). Questions placed participants in one of five
mutually exclusive Stage of Change categories based on their answers to a series of
Yes/No questions (see appendix for Stage of Change Measure). The behavioral target
or criterion for assigning an individual to the Action stage, was defined as “at least
once a week, you push yourself to approach some of the things that you often avoid
(or choose not to do) because of anxiety.” This criterion was based on evidence that
exposure to feared stimuli reduces symptoms of anxiety and impairment from anxiety.

9

For pre-action stages, participants were assigned to: Precontemplation if they indicated
that they were not currently approaching feared stimuli regularly and did not intend to
do so in the next six months; Contemplation if they were not currently approaching
feared stimuli regularly, but intended to begin doing so in the next six months; and
Preparation if they were not currently approaching feared stimuli regularly, but
intended to begin doing so in the next 30 days. Participants were assigned to Action if
they reported currently meeting the Action criterion and were assigned to Maintenance
if they reported having been engaged in this behavior for at least six months.
1.3 Data Analysis
ANOVA was used to determine whether individuals in the
Action/Maintenance stages of change showed different levels of anxiety severity and
quality of life than those in pre-Action stages. A chi-square test was used to evaluate
whether there was a significant association between participants’ treatment status (in
treatment versus not in treatment) and being in a pre-Action versus
Action/Maintenance Stage of Change.
2. Results
2.1.1 Descriptive Results
In terms of current anxiety treatment, 30.6% (n=182) were not currently in any
treatment, 41.3% (n=256) were taking medication only, 9.1% (n=54) were in
psychotherapy only, and 17.1% (n=102) were taking medication and going to
psychotherapy. Among the individuals who reported that they were in psychotherapy,
92.3% (n=144) reported that their therapist had encouraged them to engage in
exposure exercises.
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2.1.2 External Validity of SOC Action Criterion
To test validity of the Action criterion as a basis for measuring Stage of
Change, differences in anxiety levels (OASIS score) and quality of life (QLESQ-SF
score) among individuals in pre-Action versus the Action/Maintenance Stages of
Change were evaluated using ANOVA. A significant difference was observed in
OASIS scores between those in pre-Action stages versus Action/Maintenance (F (1,
592) = 5.06, p = .025, η2=.01). Individuals in Action or Maintenance (M = 12.01, SD
= 3.20) reported significantly lower levels of anxiety than individuals in the preAction stages (M = 12.60, SD = 3.06). A significant difference was also observed in
QLESQ-SF scores between those in pre-Action versus Action or Maintenance (F (1,
592) = 8.20, p < .01, η2=.01). Individuals in Action or Maintenance (M = 0.47, SD =
0.19) reported significantly higher quality of life than individuals in the pre-Action
stages (M = 0.43, SD = 0.18).
A chi-square test evaluating the relationship between Stage (pre-Action versus
Action/Maintenance) and current treatment status was significant, thereby supporting
an association (χ2(1, n=594) = 10.26, p<.01, phi=.13). Participants reporting that they
were currently engaging in approach behaviors on a regular basis (i.e., Action or
Maintenance stages) were more likely to be in treatment than not in treatment (see
Table 1 in appendix).
3. Discussion
The primary purpose of this study was to develop and evaluate the preliminary
validity of a Stage of Change algorithm for reducing anxiety-based avoidance. To our
knowledge, no other study to date has built and validated a staging algorithm for
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application to anxiety disorders. The URICA staging algorithm, has been used in
anxiety research, but this measure is difficult to score and interpret and is not best
practice when applying the TTM to a new behavior because the target of change is not
specified. Accurate assessment is key to developing population-based interventions
tailored to readiness to engage in behavior change.
Results supported the validity of the Action criterion used—at least once a
week, you push yourself to approach some of the things that you often avoid (or
choose not to do) because of anxiety. Reports of accomplishing this behavioral goal
were associated with lower levels of anxiety and impairment (OASIS scores), better
reported quality of life (QLESQ-SF scores) and higher rates of treatment seeking.
Thus, this study provides preliminary support for the developed measure of Stage of
Change to engage in approach behaviors.
This study had several limitations. First, the sample consisted of individuals
who expressed an interest in online survey research participation, which may have
introduced some sample bias. Future studies could evaluate findings in samples
collected via proactive recruitment in a community or medical settings. Second, the
sample, while nearly representative of national racial demographics, was primarily
white and female. This may limit the generalizability of findings. Third, all data were
self-reported, and there was wide variation in the length of time it took individuals to
complete the survey. As with most research that relies on self-report, these factors
raise the possibility of random and careless responding. Fourth, test-retest data was not
available in this dataset, but would be useful for further, future validation. Fifth, the
definition of Stage of Change may have provided enough information to some
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participants to make them more likely to consider change and, therefore, indicate that
they were in later Stage of Change (i.e., not Precontemplation). Finally, the ideal
external criteria for validation of the Stage of Change tool developed would have been
a behavioral measure of engagement in self- or therapy-directed exposure.
Unfortunately no such previously validated measure exists that cuts across anxiety
diagnoses. However future research could evaluate the relationship between stage and
clinician report of exposure exercise engagement or previously validated behavioral
measures of engagement in exposure designed for use in a specific diagnostic
subsample (e.g., the Liebowitz Social Anxiety Scale27 for individuals with social
anxiety disorder).
Nevertheless, this study has a number of strengths and will help guide future
investigation. It describes the development and initial validity findings for a Stage of
Change algorithm specific to anxiety treatment. This measure can be used in future
research to evaluate the impact that readiness has on treatment outcomes. It may also
be used in clinical work to inform intervention strategies (e.g., more motivational
session content versus more action-oriented session content). Finally, it may be used
in the context of intervention development to create scalable treatments that are
tailored to individuals’ readiness to change patterns of avoidance.
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Table 1.
Sample Characteristics
Variable
Participants
Sex
Male
30.6% (n=182)
Female
69.4% (n=412)
Race
White
76.4% (n=454)
Black
12.8% (n=76)
Asian
3.7% (n=22)
Other
7.1% (n=42)
Stage of Change for anxiety management
Precontemplation
14.1% (n=84)
Contemplation
3.9% (n=23)
Preparation
20.7% (n=123)
Action
17.0% (n=101)
Maintenance
44.3% (n=263)
Self-reported diagnoses (not mutually exclusive)
Panic Disorder (with or without Agoraphobia) 44.9% (n=267)
Agoraphobia (with or without Panic)
11.8% (n=70)
Obsessive Compulsive Disorder
25.6% (n=152)
Post-traumatic Stress Disorder
19.9% (n=118)
Social Anxiety Disorder
45.1% (n=268)
Generalized Anxiety disorder
52.5% (n=312)
Specific Phobia
12.1% (n=72)
Anxiety NOS
13.8% (n=82)
Diagnosed with Anxiety, but no specific disorder 4.2% (n=25)
Never diagnosed with and anxiety disorder
5.2% (n=31)
Treatment status (mutually exclusive categories)
No treatment
30.6% (n=182)
Medication only
43.1% (n=256)
Therapy only
9.1% (n=54)
Combined (medication and therapy)
17.2% (n=102)
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Appendix (to be included in manuscript submission)
Stage of Change Measure for Reducing Anxiety-Based Avoidance
Anxiety is not just feeling “stressed” or “nervous.” Anxiety is when stress or
nervousness interfere with your daily life. People who are anxious may:


Avoid events, activities, places or things that make them anxious



Have unpleasant physical feelings like racing heart, dizziness and/or upset
stomach



Experience upsetting thoughts that seem to take over their minds such as
o Worries (e.g., “what if” questions)
o Concerns about some specific thing like getting sick or dirty
o Thoughts about a traumatic past event like abuse or a car accident

At least one in four people experience anxiety at some point in their lives.
For example, managing your anxiety may mean


Committing to do things that are important to you (e.g., look for a new job or
go on a date) even if worry or anxiety makes you not want to do those things.



Pushing yourself to speak up at a meeting or give a speech to an audience.



Doing light exercise even if this is a trigger for panic attacks.



Touching things others are ok with touching, but that you often see as dirty.



Leaving your house if you become anxious when you are far away from home.



Getting on a plane if you are nervous when flying.



Allowing yourself to experience thoughts about a past trauma.
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Even though doing these things can make you feel more anxious at first, research
shows that doing them actually makes you LESS anxious over the long term.

Q1: Do you currently, at least once a week, push yourself to approach things that you
often avoid (or choose not to do) because of anxiety?
__Yes (if YES, please skip to Question 4)
__No (if NO, continue to next question)

Q2: In the next 6 months, do you intend to start managing your anxiety by, at least
once a week, pushing yourself to approach things that you often avoid (or choose not
to do) because of anxiety?
__Yes (if YES, continue to next question)
__No (if NO, this questionnaire is complete)

Q3: In the next 30 days, do you intend to start managing your anxiety by, at least once
a week, pushing yourself to approach things that you often avoid (or choose not to do)
because of anxiety?
__Yes (You are done. This questionnaire is complete.)
__No (You are done. This questionnaire is complete.)

Q4: (Only answer if you answered ‘YES’ to Question 1) For how long have you been
managing your anxiety by, at least once a week, pushing yourself to approach things
you would often avoid (or choose not to do) because of anxiety?
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__Less than 6 months (You are done. This questionnaire is complete.)
__More than 6 months (You are done. This questionnaire is complete.)

Scoring:
-Precontemplation – NO to Question 1 and NO to Question 2
-Contemplation – NO to Question 1 and YES to Question 2 and NO to Question 3
-Preparation – NO to Question 1 and YES to Question 2 and YES to Question 3
-Action – YES to Question 1 and NO to Question 4
-Maintenance - YES to Question 1 and YES to Question 4
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Abstract
Purpose. Anxiety is the most common and costly mental illness in the United States.
Avoidance is the cornerstone of anxiety, and reducing the incidence of avoidance is a
core element of evidence-based treatments. Investigating anxiety-based avoidance
from a Transtheoretical Model (TTM) perspective could facilitate development of
interventions applicable for both individuals ready and not yet ready to address their
anxiety. This study validated TTM measures of Decisional Balance and Self-efficacy
for reducing anxiety-based avoidance.
Design. Cross sectional measurement development.
Setting. Qualitative interview and online survey.
Subjects. 604 individuals, ages 18-70 with clinically significant anxiety.
Measures. Stages of Change, Decisional Balance, and Self-efficacy.
Analysis. The sample was randomly split into halves for exploratory principal
components analysis (PCA), followed by confirmatory factor analyses (CFA) to test
measurement models. Multivariate analyses examined relationships between
constructs.
Results. For Decisional Balance, PCA indicated two, 5-item factors (Pros α=0.85; and
Cons α=0.67). CFA supported a two-factor correlated model, χ²(35)=80.82, p<.01,
CFI=.94, RMSEA =.7 with Pros α=.87 and Cons α=.75. For Self-efficacy, PCA
indicated one 6-item factor (α=0.87). CFA supported this structure, χ²(9)=30.39,
p<.01, CFI=.98, RMSEA=.088, α=.90. Multivariate analyses indicated significant
cross-stage differences for Pros and Self-efficacy in expected directions.
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Conclusion. Findings support internal and external validity of these measures. Stageconstruct relationships suggest Cons for reducing avoidance may be more stable
across stages than Cons for other behavior changes. These measures may be used to
develop a computer-tailored intervention for anxiety.
Key Words: anxiety, Transtheoretical Model, Decisional Balance, Self-efficacy,
exposure therapy, Stages of Change
Indexing Key Words: Manuscript format: research; Research Purpose: instrument
development/validation; Study Design: Cross-Sectional; Outcome measure:
behavioral; Setting: population-based; Health focus: medical self-care; Strategy: skill
building/behavior change; Target population age: adults; Target population
circumstances: survey company database.
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PURPOSE
Anxiety is the most prevalent form of mental illness in the United States. It is
estimated that at least one in four people develop an anxiety disorder at some point
during his or her life.1 Compared with the general population, individuals with anxiety
disorders experience lower quality of life,2,3 educational and occupational
impairment,4-8 as well as increased risk of comorbid medical problems4,9,10 and
suicide.11,12 In addition to personal costs, anxiety disorders have a large public health
cost, accounting for about one third of total expenditures on mental illness. The annual
cost of anxiety disorders in the US is estimated to be between $42 and $46 billion
dollars.13-15
Research on the efficacy of cognitive-behavioral treatments (CBTs) for anxiety
shows consistently large effect sizes (d = 1.14 to 1.9816) and suggests 50%-80% of
patients attain clinically significant effects.17 The primary behavioral component of
evidence-based treatments for anxiety is exposure exercises, in which patients practice
facing anxiety-provoking stimuli that are progressively more emotionally
challenging.18 For example, a patient with social anxiety may complete exposure
exercises that involve a set of social activities ranging from less anxiety-provoking
(e.g., asking a close friend if he/she is interested in getting together informally) to
more anxiety-provoking (e.g., asking someone out on a date). This treatment strategy
is based on classic behavioral studies of extinction of feared responses.19-21
Research suggests that exposure exercises are key to overcoming anxiety. A
number of dismantling studies aimed at determining the active components of
evidence-based treatments for anxiety indicate that the cognitive elements of
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evidence-based therapies for anxiety do not significantly increase the efficacy of
exposure therapy. For example, exposure-only treatments have been found to be as
effective as treatments with exposure and cognitive components in treatment of social
anxiety disorder and posttraumatic stress disorder.22-26 Similarly, meta-analyses
suggest that exposure-only treatments perform equivalently to exposure plus cognitive
treatments for Generalized Anxiety Disorder, Obsessive-Compulsive Disorder, Panic
Disorder, and Social Phobia.27-32
Unfortunately, most individuals with anxiety disorders do not receive exposurebased therapy. It is estimated that as few as 4-11% of individuals with anxiety
disorders seek mental health treatment at all.33,34 Research suggests that the main
reasons for not getting treatment are: poor access (encountering logistical barriers such
as cost and availability) and intra-individual variables that affect readiness (not being
receptive to treatment or not believing one’s symptoms warrant treatment).35 In
support of the importance of intra-individual variables, studies have found that many
people with access to trained exposure therapy practitioners do not initiate or stay in
treatment. Pre-treatment attrition among patients diagnosed with anxiety disorders and
offered free therapy is 30-52%.36-38 Dropout rates among those seeking treatment are
estimated to be as high as 31%.38 Intra-individual barriers are particularly relevant in
exposure therapy because approaching feared stimuli is not an intuitive or comfortable
way to address anxiety.39
A Computer-Tailored Intervention for Anxiety
A population-based approach to anxiety disorders is needed in order to improve
the massive public health toll of this treatable mental illness. Such an approach would
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need to involve efforts to improve access to treatment and address intra-individual
variables that affect readiness to address one’s anxiety. To date, dissemination efforts
have focused on increasing access (e.g., training more providers, providing group
treatment, making treatments available in non-specialty settings39,40) rather than
reducing intra-individual barriers. A readiness-focused, Computer-Tailored
Intervention (CTI) would address both access and intra-individual barriers.
CTIs are optimal for improving reach since they are easy to access, inexpensive to
distribute, and have a strong history of effectively incorporating readiness-based
information using the Transtheoretical Model of behavior change (TTM). Such an
intervention could be used as a primary treatment for individuals without access to or
not yet ready for in-person treatment. It could also be a complement to in-person
treatment aimed at encouraging individuals with clinically significant anxiety to
engage exposure exercises or to gradually begin approaching feared stimuli.
The Transtheoretical Model Of Behavior Change (TTM)
The TTM provides an evidence-based framework for organizing CTIs that help
motivate individuals to engage in new behaviors.41 Numerous randomized controlled
trials support the effectiveness of computerized, TTM-tailored interventions targeting
a variety of behavioral and mental health issues such as exercise adoption, depression
management and domestic violence cessation.42-44 The TTM’s readiness-based
approach to behavior change is consistent with recent evidence that readiness-based
therapy techniques, such as Motivational Interviewing, enhance the efficacy of CBT
for anxiety when applied as a pre-treatment.45,46 The TTM is particularly powerful as a
theoretical basis for such an intervention because it provides empirically-based
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guidance on which intervention strategies work best in each stage, and hence
systematically meets patients where they are in terms of readiness.
The TTM posits that initiating new behavior patterns involves progressing through
a series of five Stages of Change: Precontemplation (not yet intending to take action),
Contemplation (intending to take action in the near future, but not immediately),
Preparation (taking steps necessary for action), Action (initiating the new behavior
pattern) and Maintenance (>6 months of successful action). Action is defined with
respect to the behavioral target: in the case of this study, action is readiness to engage
in exposure exercises.
According to the TTM, readiness to change is largely based on the relative weights
of the pros (advantages of change) compared with the cons (disadvantages of
change).47 A stable pattern of Decisional Balance across Stages of Change has been
observed across over 48 different health behaviors.48 In the Precontemplation Stages
of Change, the Cons outweigh the Pros. The relative weight of Pros and Cons reverses
between the Contemplation and Preparation stages, such that Pros become more
important and Cons less important.49 This pattern of change in Decisional Balance is
hypothesized to be an essential driver of progress toward Action and Maintenance.
In addition to Decisional Balance, the TTM focuses on Self-efficacy as an
important factor in an individual’s readiness to change. Self-efficacy is defined as
one’s level of confidence in one’s ability to successfully change a target behavior
across a variety of challenging situations.50 Research indicates that Self-efficacy
scores are higher in the later Stages of Change. The largest differences in Self-efficacy
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have been observed in comparisons of individuals in the Action Stage of Change with
those in the earliest Stages of Change.50,51
Goals of the Current Study
Given the serious health effects of anxiety disorders and the low rate of
utilization of evidence-based interventions, alternative models of treatment are needed.
Research indicates that the exposure process, that is the gradual confrontation of
feared internal, external and imagined stimuli, is an effective way to reduce the
severity of anxiety and impairment from anxiety. The aim of the current study is to
develop and validate measures of Decisional Balance and Self-efficacy for adults with
clinically significant levels of anxiety. This is an essential step toward the
development of a TTM-directed CTI for anxiety.
Although some research on anxiety has utilized generic Stages of Change
measures,52 no study has yet evaluated core TTM constructs that drive change such as
Decisional Balance and Self-efficacy. This study, therefore, builds upon existing
literature by developing and evaluating measures expected to be useful in increasing
self- or therapist-directed engagement in exposures for anxiety. This study also seeks
to evaluate the potential usefulness of an application of the TTM to anxiety-based
avoidance. Its findings could have a substantial impact on the way that treatment is
conceptualized and eventually delivered.
METHODS
Design
This study used a sequential process of measurement development to develop
of measures of two key TTM constructs—Decisional Balance and Self-efficacy.54-56
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Items were developed via a series of semi-structured expert and participant interviews.
Item development was followed by exploratory, confirmatory and external validation
quantitative analyses.
Item Development
Items were initially developed based on a comprehensive review of TTM
measures for other behaviors and conclusions from the literature on reasons
individuals tend to persist in avoiding things that make them anxious and on barriers
to changing avoidance patterns.
Expert Interviews
After this initial development, items were further refined using feedback from
experts in anxiety disorders and the TTM. Two, PhD- level experts in anxiety
disorders were engaged in semi-structured interviews in which they provided feedback
on the proposed set of items. Additionally, three experts in the TTM were asked to
review the proposed set of items for clarity and adherence to the theoretical
foundations of the constructs.
Qualitative Participant Interviews
Once feedback from experts was incorporated, 10 structured qualitative
interviews with anxious adults recruited from the community were conducted. The
goal of the qualitative interviews was to elicit participant feedback on item clarity,
acceptability, and face validity. In order to be eligible for participation in qualitative
interviews, individuals had to be over 18 and had to receive a score of 8 or above on
the Overall Anxiety Severity Questionnaire (OASIS).57 Qualitative interviews were
conducted in a private room in a location convenient for the participants (i.e.,
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community library, university office, or the mental health clinic from which they were
recruited). When participants arrived, they were presented with an informed consent
form, it was explained orally, and they were then given the opportunity to review the
written copy on their own before signing. No participants withdrew from the study
after reviewing informed consent form. Participants then completed a survey and
provided oral feedback in an interview format. Consistently problematic items were
discussed by the research team and eliminated or modified.
Survey Administration
The survey was administered using FluidSurveysTM online survey software.
Participants accessed the survey via an online link, which took them to the informed
consent page. Individuals were asked to check a box indicating that they had read the
informed consent form and agreed to participate. They were then routed to questions
on eligibility criteria (which were the same as those for the qualitative interviews), on
age and on level of anxiety per the OASIS. Eligible individuals were then linked to the
full survey. Data were extracted from FluidSurveysTM into SPSS for exploratory and
external validation analyses and EQS for confirmatory analyses.
Sample
Recruitment
Participants for qualitative interviews were recruited through flyers placed at
universities, community centers, and mental health treatment centers. Interested
participants were asked to call the primary investigator to get more information. When
participants called, they were presented with an informed consent form to engage in a
screening questionnaire, which included the OASIS.57 Individuals with sufficiently
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high levels of anxiety per the OASIS (>8) were given the option to participate. Twenty
individuals called expressing interest in participating and 13 of these individuals were
eligible. Of the thirteen individuals three had difficulty scheduling a time to participate
and 10 participated. Qualitative interview participants were reimbursed $20 for their
participation.
Participants for the online survey administration phase of the study were
recruited through Survey Sampling International. Eligibility criteria were added during
recruitment to ensure adequate representation across certain groups. Additional
eligibility criteria were included as follows: only non-white participants (25
completes) and only pre-Action Stages of Change (128 completes). All recruitment
and human subjects procedures were approved by the University of Rhode Island’s
Institutional Review Board.
Qualitative Interview Sample
Ten, one-on-one qualitative interviews were conducted by a doctoral student
with eligible and interested individuals. The average age of cognitive interview
participants was 36.6 and the average OASIS score was 11.3. Three of the qualitative
interview participants were recruited form a local mental health treatment center, four
were recruited from a community support center, and three were recruited from the
University of Rhode Island community. Seven of the qualitative interview participants
were male and three were non-white.
Survey Sample
A sample of N=594 individuals between the ages of 18 and 80 (M=38.62,
SD=13.84) were recruited via Survey Sampling International (SSI). The majority of
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the sample was white (n=454, 76.4%), 12.8% were Black (n=76), 3.7% Asian (n=22),
and 7.1% classified themselves as not fitting into these racial categories (n=42). Of the
594 participants, 14.1% were in Precontemplation (n=84), 3.9% were in
Contemplation (n=23), 20.7% were in Preparation (n=123), 17.0% were in Action
(n=101) and 44.3% were in Maintenance (n=263). The majority of the sample was in
some form of treatment for their anxiety (69.4%, n=412). 43.1% of the sample was
taking medication without therapy (n=256), 9.1% was in therapy only (n=54), and
17.2% was taking medication and was in therapy (n=102).
Measures
Measures Used
Overall Anxiety Severity and Impairment Scale (OASIS).58 The OASIS was
used to determine eligibility to participate. The OASIS is a 5-item self-report measure
that evaluates severity and impairment associated with any anxiety disorder.
Participants rate the degree to which each item describes himself or herself over the
past week on a 5-point scale ranging from 0 (None) to 4 (Extreme/All the Time). A
score of 8 or greater has been found to accurately classify 87% of individuals as
having an anxiety diagnosis.57 This scale was selected based on strong psychometric
properties, adequate coverage of symptoms relevant for all anxiety diagnoses, and ease
of use (i.e., short length, free access, and easy scoring). Good internal (α=0.80) and
one-month test-retest reliability (κ = 0.82) have been reported. Research shows strong
convergent validity with other measures of anxiety.58
Measures Developed
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Stage of Change. Participants were asked to answer a series of questions about
whether they regularly (at least once a week) approach things they would usually
avoid because of anxiety. These questions placed participants in one of five mutually
exclusive Stages of Change categories. The Action criterion, which was phrased
“managing your anxiety,” was defined as “at least once a week, you push yourself to
approach some of the things that you often avoid (or choose not to do) because of
anxiety.” This action criterion was based on the evidence that exposure to feared
stimuli reduces anxiety and impairment.
Participants were assigned to a Stage of Change category based on their
answers relative to the Action criterion. They were put in the Precontemplation stage
if they indicated that they were not currently approaching feared stimuli regularly and
did not intend to do so in the next six months; to Contemplation if they intended to
begin doing so in the next six months; and to Preparation if they intended to begin
doing so in the next 30 days. Participants were assigned to the Action stage if they
were currently approaching feared stimuli regularly, but had been doing so for less
than six months, and to Maintenance if they had been doing so for six months or
longer.
Decisional Balance. Twenty items were used to create the Decisional Balance
scale. Ten items represented the Pros of approaching feared stimuli regularly and ten
reflected the Cons of approaching feared stimuli regularly. Respondents were asked to
indicate how important each item was in their decision of whether to change
avoidance patterns on a 5-point Likert scale ranging from 1 = ‘Not Important at All’ to
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5= ‘Extremely Important.’ The score for this scale was the sum of participant’s
responses.
Self-efficacy. Ten items were used to develop the Self-efficacy scale. Items
evaluated participants’ confidence in their ability to approach feared stimuli regularly
in a variety of challenging situations (e.g., when their schedules become busy).
Participants indicated their confidence levels on a 5-point Likert scale, ranging from 1
= “Not at All Confident” to 5 = “Extremely Confident. The total score for this scale
consisted of the sum of the participant’s responses.
Analysis
Three phases of analyses were conducted: exploratory, confirmatory, and
external validation. The sample was randomly split such that one half could be used
for the Principal Components Analyses (PCAs, n=289). PCAs were conducted to
determine the number of components and reduce scales to a smaller set of items. Item
selection was an iterative process that involved removing items for quantitative
reasons (loadings <.40, correlations >.70 with other items, or high loadings on
multiple factors) and qualitative reasons (to avoid redundancy and maintain the
conceptual breadth of construct). In the second phase of analysis, Confirmatory Factor
Analyses (CFAs) were conducted using the second half of the sample (n=305). CFAs
were used to evaluate the degree to which an independent portion of the data fit the
model created by iterative PCAs. Model fit and factor loadings were evaluated.
Finally, external validation analyses were conducted with the full sample (N=594). In
this phase, MANOVA was used to evaluate the relationships between Decisional
Balance factors and Stage of Change. ANOVA was used to evaluate the relationship
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between Self-efficacy and Stage of Change. Relationships were evaluated for
consistency with patterns seen for other health behaviors.48 Linear regressions were
also conducted to evaluate whether predicted relationships between TTM constructs
and severity of anxiety were observed.
RESULTS
Exploratory Analyses
Exploratory procedures included PCA with varimax rotation. Sample size
(n=289) was adequate based on existing literature.59,60. Decisions regarding retention
of components were based on parallel analysis61 and minimum average partial
procedures (MAP),62 both of which have been found to be accurate methods.63
Exploratory analyses were used to determine the number of components, the
correlations between components, and the loadings of items on these components.
Items with poor (<.40) and complex loadings (>.40 on more than one factor) were
removed. In later steps of exploratory analyses, items that had content that overlapped
with items that had higher loadings were also removed.
Decisional Balance
The initial PCA included twenty Decisional Balance items. In total, five PCAs
were conducted. These reduced the measures to 10 items equally representing the Pros
and Cons of regularly approaching feared stimuli. MAP and parallel analysis
supported a two-component solution. Final item loadings ranged from .53 to .83.
Internal consistency was good for the 5-item Pros scale (α = .86) and adequate for the
5-item Cons scale (α = .67). Together the two factors accounted for 53.96% of the
total item variance.
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Self-efficacy
The initial PCAs included ten Self-efficacy items. Four PCAs were conducted,
which reduced the original ten items to six. MAP and parallel analysis supported a
single component solution. Item loadings ranged from .76 to .83. The final set of six
items had good internal consistency (α = .87) and accounted for 62.67% of the total
item variance.
Confirmatory Analyses
Confirmatory factor analyses were conducted with the structural equation
modeling software EQS using the remaining subsample (n=305).64 Sample size was
adequate based on existing literature.59 Robust estimation methods were used for fit
indices since item data was ordinal.59 The fit indices calculated were the SatorraBentler scaled chi-square, the comparative fit index (CFI), and the absolute
standardized residual statistic (AASR). Traditionally, CFI values of 0.90 and above
are considered to indicate good fit.65 RMSEA values between .05 and .08 suggest
reasonable error of approximation and values >1 indicate poor fit.66
Decisional Balance
The following measurement models were compared for the ten-item Decisional
Balance measure: (1) a null model that supported ten independent variables and no
latent factors; (2) a two-factor uncorrelated model; and (3) a two-factor correlated
model. Fit indices for each model are summarized in Table 1.
The two-factor correlated model showed the best fit to the data. Factor
loadings ranged from .49 to .83. Fit indices suggested strong model fit, χ²(34)=68.23,
p<.01, CFI=.95, RMSEA =.06. The correlation between the two scales was r=0.28 and
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coefficient alphas were good for Pros (α = .87) and acceptable for Cons (α = .75). The
final items and their loadings in the confirmatory subsample are presented in Figure 1.
Self-efficacy
The following measurement models were compared for the Self-efficacy scale:
(1) a null model that supported six independent variables and no latent factors and (2)
a single factor model. The one-factor model had the best fit. Factor loadings ranged
from .67 to .86 and there was excellent model fit, χ²(9)=30.39, p<.01, CFI=.98,
RMSEA =.09. Internal consistency was excellent (α = .90). Final items and their
loadings are presented in Figure 2.
External Validation
External validity was evaluated in two ways. First, the relationship between
TTM constructs and Stages of Change was evaluated and compared to patterns seen in
other areas of behavior change (Figure 3 and Figure 4). Raw TTM construct scores
(see Table 2) were translated to T scores and weighted by group size to eliminate bias
created from uneven Stage groups. Second, relationships between TTM constructs and
anxiety severity were evaluated for predicted relationships.
Decisional Balance by Stages of Change
Multivariate analysis of variance (MANOVA) indicated the individuals at
different Stages of Change (vis-a-vis regularly approaching feared experiences)
differed significantly on Decisional Balance constructs (F (8, 584) = 4.27, p<0.01, 2=
.028). Follow-up ANOVAs indicated that there were significant between-stage
differences on the Pros (F (4, 589) = 7.94, p<.01, 2=0.05). Post-hoc analyses
indicated that the Pros were significantly higher for individuals in the Action and
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Maintenance stages than for those in the Precontemplation stage. Pros showed a
maximum average difference of .62 standard deviation units between
Precontemplation and Maintenance. No significant between-stage differences were
observed on the Cons (F (4, 589) = 0.75, p=0.56, 2=0.005). Cons showed a maximum
average difference of .30 standard deviation units. Weighted T Scores of Pros and
Cons at each Stage of Change are presented in Figure 3.
Self-efficacy by Stages of Change
Analysis of variance (ANOVA) indicated that Self-efficacy was significantly
different across the Stages of Change, F(4, 589) = 10.13, p<.01, 2=0.06. Follow-up
comparisons showed that Self-efficacy of individuals in the Precontemplation and
Preparation stages was substantially lower than that of those in the Action and
Maintenance stages. Self-efficacy was .69 of a standard deviation unit higher among
individuals in Action compared to individuals in Precontemplation. Weighted T
Scores of Self-efficacy at each Stage of Change are presented in Figure 4.
Relationships Between TTM Constructs and Severity of Anxiety
A series of linear regressions were performed to evaluate the relationship
between anxiety severity (OASIS) and TTM constructs (Pros, Cons, and Self
Efficacy). Results indicated that higher perceptions of the importance of the Pros of
managing anxiety was associated with more severe levels of anxiety (β = 0.17, p<.01).
Higher perceptions of the importance of the Cons of managing anxiety were also
associated with more severe levels of anxiety (β = 0.25, p<.01). Finally, higher Selfefficacy was associated with lower levels of anxiety severity (β = -0.29, p<.01).
DISCUSSION
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This is one of the first studies to apply the TTM, beyond generic Stages of
Change measures, to anxiety. Measurement development results demonstrated good
construct validity for two TTM scales, one measuring Decisional Balance and the
other measuring Self-efficacy, in a large national sample of adults with clinically
significant levels of anxiety. Both scales also demonstrated good external validity in
terms of their relationship with Stages of Change. Data on average scores in each
Stage of Change on these scales can be used in future research as the foundation for a
CTI.
Decisional Balance
Through a sequential process of measurement development, this research
supported a two factor correlated model for the Decisional Balance scale with one
factor representing the Pros and the other the Cons of reducing anxiety-based
avoidance. A two-factor model for Decisional Balance has been observed across many
health risk behaviors. The findings are also consistent with the broader literature on
Decisional Balance insofar as the Cons outweighed the Pros in Precontemplation, Pros
are nearly equal to Cons in Contemplation, and there was a crossover in perceived
importance of Pros versus Cons in the Contemplation Stage of Change.49 Also, Pros
rose significantly as people progressed to the Action and Maintenance Stages of
Change.48,49
Findings also showed some differences between Decisional Balance applied to
anxiety-based avoidance and Decisional Balance in other problem areas. First, the
change in Pros was lower in magnitude than has been observed in other behavior
areas. The change in Pros was 0.62 standard deviation units and changes closer to 1.0
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standard deviation units are typically observed.48,49 One interpretation of this is that
Pros of changing anxiety-based avoidance may be fairly important even when
individuals are not taking action. Second, cross-stage differences in the perceived
importance of Cons were not significant, so even among individuals who were
regularly approaching feared stimuli, the downsides of challenging their anxiety in this
way felt important. This may be one reason why drop out rates from evidence-based
treatments are high. If these findings are replicated in future research, CTIs may
benefit from a greater focus on feedback to increase the salience of Pros rather than to
reduce the perceived importance of Cons.
The positive relationship between the severity of anxiety and both perceived
Pros and Cons of approaching anxiety-producing stimuli provided further external
validation for the Decisional Balance measure. It was predicted that individuals with
high anxiety would be keenly aware of the upsides of reducing avoidance. It was also
predicted that the higher one’s anxiety would be more aware of the Cons of
approaching feared-stimuli. Findings confirmed both predictions.
Self-efficacy
As hypothesized, results supported a single factor scale assessing Self-efficacy.
Confirmatory fit indices for the Self-efficacy scale showed good fit. As observed in
other areas of behavior change, Self-efficacy was greater among individuals in the
Action and Maintenance stages than in the pre-Action stages. Contemplation was an
exception insofar as the difference between Self-efficacy in Contemplation and that in
Action and Maintenance was not significant, however, this finding may be a result of
the small sample size of participants in Contemplation.51,67 Therefore, it appears that
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individuals in more advanced Stages of Change for approaching anxiety-producing
stimuli report greater situational Self-efficacy. Finally, the significant relationship
between higher Self-efficacy and lower severity of anxiety provides additional
external validation for this measure. These results support the validity of this scale and
indicate that Self-efficacy may be a fruitful construct for feedback in a CTI aimed at
reducing anxiety-based avoidance.
Limitations & Future Directions
This study has several limitations. First, approximately 60% of this sample was
in Action or Maintenance and less than 4% was in Contemplation. Sample sizes were
adequate for principle component analyses and structural equation modeling
conducted and scores were weighted by sample size for external validation analyses.
Nevertheless the small Contemplation sample size likely limited the power for
comparisons with other stage groups. Additionally, the dominance of individuals in
Action and Maintenance may have affected observed loadings. Future research reevaluating findings in a pre-Action sample is warranted. Second, findings are based on
cross-sectional comparisons of individuals in each Stages of Change. Cross-sectional
findings provide some insight into factors that drive change, but do not necessarily
have longitudinal implications. Finally, present findings are based on a sample of
convenience. Although efforts were made to recruit a racially and ethnically diverse
group of participants the vast majority of participates were white and non-Hispanic.
Representation of minorities is not too disparate from national or racial minority
representation according to US Census data, but additional research looking at the
validity of developed measures in non-white groups would shed light on the
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generalizability of these measures. The sample was also not representative of
treatment-seeking rates in the general population insofar as the majority of participants
were in some sort of treatment for anxiety. Further evaluation of both validity and
stage-construct relationships is needed in a sample of non-treatment seeking, anxious
adults.
This study suggests several useful directions for future investigation. First,
these findings should be evaluated longitudinally and in minority populations. Second,
developing measures for the Processes of Change will be a key step toward building
theoretically sound, population-based, computer-tailored intervention for managing
anxiety. Finally, this study calls for further investigation into potential differences in
the change process for behaviors aimed at improving emotional health, especially in
the pattern observed in Decisional Balance variables.
Conclusions
Anxiety disorders are a major public health concern both in terms of personal and
societal cost. Exposure-based therapy for anxiety disorders, which involves reducing
avoidance or approaching successively more anxiety-provoking stimuli, is effective,
but only a minority of the population of individuals with anxiety disorders engage in
such treatment. This study developed and applied constructs from the TTM to
approaching anxiety-provoking stimuli as an individual would do in evidence-based
psychotherapy for anxiety.
Results show considerable consistency with observations from other behaviors in
that a two-factor Decisional Balance scale and one-factor Self-efficacy scale provided
the best fit to the data. Also consistent with theory-based predictions, participants in
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later Stages of Change scored higher on Pros and higher on Self-efficacy than
individuals in earlier Stages of Change. Scales also showed a sound relationship with
anxiety severity. The scales developed in this study may be useful for a variety of
purposes, including assessing readiness to engage in exposures in the context of
intervention and research. Computerized interventions that provide feedback tailored
to Stage of Change and other TTM constructs like Decisional Balance and Selfefficacy, have been found to be an effective population-based intervention in a variety
of other areas of behavior change.42,68-70 Such an approach may be necessary to
improve the impact of evidence-based treatments for anxiety such that we are
intervening on the full population of individuals with anxiety disorders.
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SO WHAT?
What is already known on this topic?
Exposure-based treatment for anxiety is effective, but reach of these treatments is
limited owing to limited access and other individual variables like beliefs about
treatment and motivation. Research efforts to date have focused on increasing access
and less on understanding motivational influences and how to intervene on them.
What does this article add?
This article described development and validation of Self-efficacy and Decisional
Balance scales, two constructs that have been found to mediate behavior change for
many behaviors. The relationship between these scales and readiness to change
supports their importance in reducing avoidance in anxious individuals.
What are the implications for health promotion, practice, or research?
Utilization of the Transtheoretical model allows the field to move beyond treatment
studies based on an action-ready paradigm and traditional modes of in-person
treatment that are not likely to dramatically increase utilization. These measures can
be used as the basis for a population-based CTI.
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Table 1.
Robust Method Fit Indices for Evaluated Decisional Balance and Self-Efficacy Confirmatory Models
χ²(df)

CFI

RMSEA (CI)

Model 1: null model

788.80 (45)*

--

--

Model 2: uncorrelated two factor model

80.82 (35)*

.938

.066 (.047, .084)

Model 3: correlated two factor model

68.23 (34) *

.954

.058 (.037, .077)

907.42(15) *

--

--

30.39(9) *

.976

.088 (.055, .124)

Decisional Balance
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Self-efficacy
Model 1: null model
Model 2: one factor model

Note. N = 305; χ² = chi square; df = degrees of freedom; CFI = comparative fit index; RMSEA = root mean
square error or approximation; CI = confidence interval; *p<0.01.
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Table 2.
Summary of Raw Scores on Pros, Cons, and Self-Efficacy by Stage
Pros

56

Stage

N

Mean

S.D.

Mean

Cons
S.D.

Self-Efficacy
Mean
S.D.

Precontemplation

84

18.21

4.64

15.76

3.99

12.85

5.68

Contemplation

23

19.30

4.03

14.96

4.45

14.13

3.31

Preparation

123

20.58

4.28

15.72

4.10

13.49

4.24

Action

101

20.71

3.63

15.91

4.54

16.28

5.21

Maintenance

263

20.78

3.44

16.25

4.40

15.82

5.21

Note. Mean = average sum score, higher scores indicate more importance for Pros and Cons and more confidence for Self-Efficacy;
S.D. = standard deviation.
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Figure 1.
Decisional Balance Structural Model (N=305)

If I managed my anxiety, I
would be able to do things that
are important to me.

Purposefully doing some of the
things that make me anxious
would be upsetting.

I would be more fun to spend
time with if I managed my
anxiety.

.77
.28

57

.66
Managing my anxiety would
improve my health.

Managing my anxiety could
improve my relationship with
others.

Managing my anxiety would
make me feel like a stronger
person.

Trying to do some of the things
that make me anxious could be
embarrassing.

.66
.59
Pros
(α=.87)

.79

Cons
(α=.75)

.49

.83

.64

.74

.70

CFI = .95
RMSEA = .06 (CI: .04, .08)
Χ2 = 68.23* (df = 34)
57

Managing my anxiety would
take resources (time and
money) I don't have.

If managing my anxiety made
me less anxious, others would
expect more from me.

I am concerned that if I tried to
manage my anxiety it may get
worse.

Figure 2.
Self-Efficacy Structural Model (N=305)
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Figure 3.
Stage of Change by Decisional Balance

55
54
53
52

T-Score

51
50
49
48

Pros

47

Cons

46
45
PC (n=84)

C (n=23)

PR (n=123)

A (n=101)

M (n=263)

Stage
Note. PC = Precontemplation; C = Contemplation; PR = Preparation; A = Action; M =
Maintenance.
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Figure 4.
Stage of Change by Self-efficacy

55
54
53
52

T-Score

51
50
49
48
47
46
45
PC (n=84)

C (n=23)

PR (n=123)

A (n=101)

M (n=263)

Stage
Note. PC = Precontemplation; C = Contemplation; PR = Preparation; A = Action; M =
Maintenance.
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Abstract
Anxiety is the most prevalent form of mental illness. Effective treatments exist,
but are underutilized. Treatments vary but uniformly involve reducing avoidance of
anxiety-producing stimuli. The Transtheoretical Model (TTM) provides a theoretical
framework for designing interventions that improve reach. This study describes the
development and validation of a measure of Processes of Change (POC), a core TTM
construct representing the emotional, cognitive and behavioral elements of the change
process. Cross-sectional measurement development with online survey dissemination
was used in 594 adults reporting clinically significant anxiety. Confirmatory analyses
replicated the theoretically-expected structure of the POC scales. Most effect sizes
were in the medium range, indicating that POC represent important behavior change
strategies for reducing anxiety-based avoidance. Relative effect sizes for the POCs
indicate which POCs individuals with low readiness may need to focus on. The
resulting measure can be used to design interventions that both increase readiness and
guide those ready to take action.

Keywords
Transtheoretical Model, Processes of Change, Anxiety, Exposure, Readiness
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Anxiety is the most prevalent form of mental illness in the United States. Lifetime
prevalence estimates indicate that a quarter of the general population in the United
States will experience an anxiety disorder at some point in his or her life (Kessler et
al., 2005). Compared to the general population, individuals with anxiety disorders
experience lower quality of life as well as educational and occupational impairment
(Barrera & Norton, 2009; Breslau, Lane, Sampson, & Kessler, 2008; Comer et al.,
2011; R C Kessler, 2003; Lee et al., 2009; Olatunji, Cisler, & Tolin, 2007; Patel,
Knapp, Henderson, & Baldwin, 2002). They are also more likely to develop comorbid
medical problems and more likely to commit suicide (Bolton et al., 2008; Comer et al.,
2011; Harter, Conway, & Merikangas, 2003; Katon, Lin, & Kroenke, 2007; Sareen et
al., 2005). Alongside these substantial personal costs, anxiety disorders have a large
public health cost. They account for approximately a third of total expenditures on
mental illness and have an annual estimated cost in the US ranging from $42 to $46
billion dollars (DuPont et al., 1998; Greenberg et al., 1999; Stein et al., 2005)
Many randomized control trials indicate that cognitive-behavioral treatments
(CBTs) for anxiety are effective. Effect sizes for these treatments are consistently
large (d = 1.14 to 1.98; Norton & Price, 2007), and a majority of patients show a
positive response to these treatments (Barlow, Allen, & Choate, 2004). Exposure—the
process of confronting stimuli that the patient would usually avoid because of anxiety,
starting with less anxiety-provoking stimuli and working up to more difficult
stimuli—is a key component of evidence-based behavioral treatments for anxiety
(Norton & Philipp, 2008). Dismantling studies aimed at determining the active
components of evidence-based treatments for anxiety indicate that exposure-only
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treatments often perform as well as evidence-based therapies with exposure plus
cognitive components (Deacon & Abramowitz, 2004; Eddy, Dutra, Bradley, &
Westen, 2004; Feske & Chambless, 1995; Foa et al., 2005; Gould, Otto, Pollack, &
Yap, 1997; Hope, Heimberg, & Bruch, 1995; Lovell, Marks, Noshirvani, Thrasher, &
Livanou, 2001; Ougrin, 2011; Paunovic & Ost, 2001; Rosa-Alcazar, Sanchez-Meca,
Gomez-Conesa, & Marin-Martinez, 208; Scholing & Emmelkamp, 1993).
Unfortunately, most individuals with anxiety disorders do not receive exposurebased therapy. Only 4-11% of individuals with anxiety disorders seek mental health
treatment at all (Mojtabai, Olfson, & Mechanic, 2002; Young, Klap, Sherbourne, &
Wells, 2001). Research suggests that the main reasons for not getting treatment are:
poor access (encountering logistical barriers such as cost and availability) and intraindividual variables that affect readiness (not being receptive to treatment or not
believing one’s symptoms warrant treatment; Weisberg, Dyck, Culpepper, & Keller,
2007). Intra-individual barriers are particularly relevant in exposure therapy because
approaching feared stimuli is a difficult and counterintuitive way to address anxiety
(Gunter & Whittal, 2010). To date, efforts to improve the reach of evidence-based
treatments for anxiety have focused on increasing access, for example by training
more providers, providing group treatment, making treatments available in nonspecialty settings (Gunter & Whittal, 2010; McHugh, Murray, & Barlow, 2009), rather
than reducing intra-individual barriers.
The Transtheoretical Model Of Behavior Change (TTM)
The TTM provides an integrative framework for developing interventions that are
relevant to the full population of individuals exhibiting a particular problem behavior
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(e.g., anxiety-based avoidance) rather than the smaller segment of the population who
are ready to take action (Prochaska & DiClemente, 1983). Numerous randomized
controlled trials support the effectiveness of interventions that provide both tailored
feedback based on individuals’ use of particular readiness-matched behavioral and
cognitive elements of the change process. Such TTM-tailored interventions have been
used to promote behavior change in a variety of areas ranging from engaging in
physical activity to managing depressive symptoms to reducing domestic violence
(Levesque, Ciavatta, Castle, Prochaska, & Prochaska, 2012; Levesque et al., 2011;
Marcus et al., 1998).
The TTM posits that individuals differ in their readiness to make changes.
Readiness is classified within five dynamic Stages of Change: Precontemplation (not
intending to take action in the foreseeable future), Contemplation (intending to take
action in the near future, but not immediately), Preparation (intending to take action in
the immediate future), Action (initiating the new behavior pattern) and Maintenance
(>6 months of successful behavior change). These stages are conceptualized as
dynamic in that individuals frequently migrate between stages both in the direction of
progress toward change and in the direction of regression away from change.
Alongside this temporal classification of change are two other constructs—
Decisional Balance and Self-efficacy—which represent the “why” part of the change
process. Decisional Balance refers to an individual’s perception of the relative weights
of advantages and disadvantages of change (Velicer, DiClemente, Prochaska, &
Brandenburg, 1985). Self-efficacy refers to an individual’s level of confidence in his
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or her ability to change a target behavior in a variety of challenging situations
(Velicer, Diclemente, Rossi, & Prochaska, 1990).
The TTM also specifies ten Processes of Change (POC) that describe the
“how” part of behavior change. The POC are a set of cognitive, emotional and
behavioral experiences or strategies in which individuals engage at different points of
the change process (DiClemente & Prochaska, 1982; Prochaska, Velicer, DiClemente,
& Fava, 1988). These POC are conceptualized as ten independent but interrelated
variables that influence Decisional Balance and Self-efficacy and can be used to
promote successful change. The 10 POC include two groups: experiential POC which
are the cognitive and emotional aspects of the change process and behavioral POC
which are the overt activities that facilitate change (DiClemente & Prochaska, 1982;
Prochaska, DiClemente, & Norocross, 1992). Experiential POCs include
Consciousness Raising (increasing information about how change could impact one’s
life), Dramatic Relief (emotional reactions to the problem behavior), Environmental
Reevaluation (assessing how the problem behavior affects one’s environment), Selfreevaluation (assessing conflicts between one’s sense of self and the problem
behavior), and Social Liberation (increasingly recognizing alternatives to the problem
behavior). Behavioral POCs include Self Liberation (affirming one’s commitment to
change), Reinforcement Management (rewarding oneself or receiving rewards for
taking steps toward change), Helping Relationships (increasing social support for
behavior change), Counterconditioning (substituting problem behaviors with healthier
behaviors), and Stimulus Control (increasing cues for positive behaviors and removing
cues for the behavior one is trying to change; Prochaska et al., 1992).
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The relationship between Stage of Change and POC is not uniform across
problem behaviors. For example, in smoking and substance abuse, experiential POC
are used more frequently in pre-Action stages of change and behavioral POC are used
more frequently in Action and Maintenance (Prochaska, Velicer, Diclementa, & Fava,
1988; Rosen, 2000). In behaviors such as insufficient exercise and unhealthy dietary
habits, use of both behavioral POC and experiential POC seem to either remain steady
or increase from earlier to later stages of change (Gorely & Gordon, 1995; Beth H
Marcus, Rossi, Selby, Niaura, & Abrams, 1992; Oliveira, Anderson, Auld, & Kendall,
2005). One theory on these differences is that the type of behavior (e.g., acquisition
behaviors where a new activity is being initiated versus cessation behaviors where a
problematic behavior is being stopped) may determine the pattern of POC use across
stage (Rosen, 2000). Creating interventions tailored to individuals’ readiness to
change a given behavior requires an understanding of which POCs are most important
at each level of readiness.
Current Study
Applications of the TTM to anxiety have been limited. Several studies have
evaluated the relationship between various treatment factors (initiation, dropout and
treatment outcomes) and Stage of Change (Al-Asadi, Klein, & Meyer, 2014; Pinto,
Pinto, Neziroglu, & Yaryura-Tobias, 2007; Reid, Nair, Mistry, & Beitman, 1996;
Woolf et al., 2006). Also, while not directly related to the TTM, several recent studies
have shown improved treatment engagement and clinical outcomes when readinessenhancing interventions like Motivational Interviewing and Motivational
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Enhancement Therapy (MET) are used as pretreatments for CBT (Buckner &
Schmidt, 2009; Westra, Arkowitz, & Dozois, 2009; Westra & Dozois, 2006).
In order to design anxiety interventions using a TTM framework, core
constructs of the TTM as they relate to anxiety must be defined and measureable. The
current study builds upon existing literature (which suggests that readiness affects
treatment outcomes) by defining a core TTM construct, Processes of Change, as it
relates to anxiety. Specifically, in this study a POC measure for anxiety-based
avoidance—the central behavior change target for evidence-based treatments for
anxiety—was developed and evaluated for validity. Secondary aims were to evaluate
the relationship between the TTM POCs and readiness to address anxiety-based
avoidance and to develop data-driven guidelines for POC use across stages. This could
guide tailoring algorithms for a computer-delivered, readiness enhancing, intervention
for anxiety.
METHODS
Measure Development Process
A sequential process of measurement development was used in this study
(Jackson, 1970; Redding, Maddock, & Rossi, 2006). This approach involves item
development and refinement via literature review, expert interviews and qualitative
interviews with individuals in the population of interest. Data are then collected on the
items developed, and a series of structural equation modeling analyses are used to
refine the POC scales. Finally, external validation analyses are conducted. These
involve testing for predicted relationships between POC use and other TTM constructs
such as stage, Decisional Balance and Self-efficacy.
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Item Development. For this study, item development involved interviews with
two anxiety experts. Items generated were then blindly rated for construct consistency
by six TTM experts. Items that were not classified as measuring the intended Process
of Change by a majority of TTM expert raters (i.e., at least 4 out of 6) were excluded
from final survey used for data collection.
Items developed via expert interviews were further evaluated via qualitative
interviews with individuals from the population of interest. Qualitative interviews
were intended to check items for clarity, acceptability, and face validity. Items that
consistently raised questions or other problems among the interviewees were
discussed by the project team and eliminated or modified. Interviews were conducted
until data saturation was reached (n=10).
Data Analyses. Data for structural equation modeling analyses were collected
by Survey Sampling International (SSI), an online survey sampling company, using
FluidSurveysTM online survey software. Data were extracted from FluidSurveysTM into
both EQS for structural equation modeling analyses and SPSS for external validation
analyses.
Iterative Confirmatory Factor Analyses (CFAs) were the primary tool used for
measurement development. The aims of these analyses were to (1) generate estimates
factor loadings and (2) evaluate internal consistency for each factor using Cronbach’s
alpha. Item selection was an iterative process in which items with poor loadings
(<.40), complex loadings (>.40 on more than one factor), as well as items with lower
loadings and content redundancy were removed. Analyses were then repeated. Final
item selection was also based on item clarity and conceptual breath.
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Once the final set of items was selected, alternative measurement models were
compared using CFA to determine which factor structure provided the best fit to the
data. Robust estimation methods (as opposed to maximum likelihood methods) were
used given the ordinal nature of measurement data. In order to determine the model
with the best fit, three fit indices were used: the Satorra-Bentler scaled chi-square
statistic (Χ2), the comparative fit index (CFI), and the root mean square error of
approximation (RMSEA). Traditionally, CFI values of 0.90 and above are considered
to indicate good fit (Hu & Bentler, 1999). RMSEA values between .05 and .08 suggest
reasonable error of approximation, and values >1 indicate poor fit (Browne & Cudeck,
1993).
External validation involved evaluating the degree to which data confirmed the
TTM-based prediction that (i) individuals in different Stages of Change will differ
significantly on their scores for the POC subscales and (ii) POCs will be correlated
with other TTM constructs. Multivariate Analysis of Variance (MANOVA) was
conducted to evaluate differences in POC across stage. To facilitate comparison
between the magnitude of differences across stage in scores among the different
subscales and the results of the current and previous studies, raw scores were
converted to T-scores (M = 50, SD = 10). Correlations between POC subscales and
other TTM variables (Pros, Cons and Self-Efficacy) were also examined.
Participants
Recruitment. To be eligible for either phase of the study (qualitative
interviews or online survey administration), individuals had to be over the age of 18
and score an 8 or above on the Overall Anxiety Severity and Impairment Scale
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(OASIS), which has been found to indicate clinically significant anxiety (CampbellSills et al., 2009). Participants for qualitative interviews were recruited through flyers
placed at universities, community centers, and mental health treatment centers. Flyers
directed interested participants to call the primary investigator, at which point they
were consented to engage in a screening questionnaire for eligibility (age and OASIS
score). Twenty individuals called to express interest in participating. Thirteen of these
individuals were eligible to participate and ten opted to come in for qualitative
interviews. Qualitative interview participants were reimbursed $20 for their
participation. The sample for the online survey administration was recruited through
Survey Sampling International, an online survey sampling company.
Sample Characteristics. Ten individuals participated in qualitative interviews.
The average age of cognitive interview participants was 36.6 and the average OASIS
score was 11.3. Three of the qualitative interview participants were recruited from a
local mental health treatment center, four were recruited from a community support
center, and three were recruited from the University of Rhode Island community.
Seven of the qualitative interview participants were male and three were non-white.
SSI recruited 594 eligible adults to participate in the online survey portion of
this study. The sample was primarily female (69.4%, n=412), and ages ranged from 18
to 80 (M = 38.6, SD = 13.8). The majority of the sample was White (n=454, 76.4%),
12.8% were Black (n=76), 3.7% were Asian (n=22), and 7.1% classified themselves as
not fitting any of these racial categories (n=42). Of the 594 participants, 14.1% were
in Precontemplation (n=84), 3.9% were in Contemplation (n=23), 20.7% were in
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Preparation (n=123), 17.0% were in Action (n=101), and 44.3% were in Maintenance
(n=263).
Measures
Measures Used
Overall Anxiety Severity and Impairment Scale (OASIS; Norman, HamiCissell, Means-Christensen, & Stein, 2006). The OASIS was used to determine
eligibility for participation. The OASIS is a 5-item self-report measure that evaluates
severity and impairment associated with any anxiety disorder. Participants rate the
degree to which each item describes them over the past week on a 5-point scale
ranging from 0 (None) to 4 (Extreme/All the Time). A cutoff score of 8 or greater has
been found to accurately classify 87% of individuals as having an anxiety diagnosis
(Campbell-Sills et al., 2009). This scale was selected based on its strong psychometric
properties, adequate coverage of symptoms relevant for all anxiety diagnoses, and ease
of use (i.e., short length, free access, and easy scoring). Good internal (α=0.80) and
one-month test-retest reliability (κ = 0.82) have been reported. Research shows strong
convergent validity with other measures of anxiety (Norman, Hami-Cissell, MeansChristensen, & Stein, 2006).
Stage of Change. Participants were asked to answer a series of questions about
whether they regularly challenge their tendency to avoid anxiety-producing stimuli.
Questions placed participants in one of five mutually exclusive Stage of Change
categories. The behavioral target or criterion for assigning an individual to the Action
stage, was defined as “at least once a week, you push yourself to approach some of the
things that you often avoid (or choose not to do) because of anxiety.” This criterion
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was based on evidence that exposure to feared stimuli reduces symptoms of anxiety
and impairment from anxiety. For pre-action stages, participants were assigned to
Precontemplation if they indicated that they were not currently approaching feared
stimuli regularly and did not intend to do so in the next six months; Contemplation if
they were not currently approaching feared stimuli regularly, but intended to begin
doing so in the next six months; and Preparation if they were not currently
approaching feared stimuli regularly, but intended to begin doing so in the next 30
days. Participants were assigned to Action if they reported currently meeting the
Action criterion and were assigned to Maintenance if they reported having been
engaged in this behavior for at least six months.
Decisional Balance. The Decisional Balance scale included 10 items designed
to assess the relative importance of Pros (5 items) and Cons (5 items) of reducing
anxiety-based avoidance. Examples of items were “managing my anxiety could
improve my relationship with others” (Pro) and “trying to do some of the things that
make me anxious could be embarrassing (Con). Ratings were based on 5-point Likert
scale ranging from 1 = ‘Not Important at All’ to 5= ‘Extremely Important.’ The score
for this scale was the sum of a participant’s responses.
Self-efficacy. Six items were used to develop evaluate Self-efficacy or
participants’ confidence in their ability to approach feared stimuli regularly in a
variety of challenging situations (e.g., “when my schedule is very busy”). Participants
indicated their confidence levels on a 5-point Likert scale, ranging from 1 = “Not at
All Confident” to 5 = “Extremely Confident. The total score for this scale consisted of
the sum of the participant’s responses.
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Measures Developed
Processes of Change. An initial pool of 93 items reflected the 10 POC.
Participants were asked to rate the frequency in which they engaged in an array of
cognitive, behavioral and emotional reactions to their anxiety and the avoidance it
encourages. Participants indicated the frequency with which they engaged in each
activity on a 5-point Likert scale, ranging from 1 = “Never” to 5 = “Frequently” (final
items listed in Table 1).
RESULTS
Processes of change
The 10-factor fully correlated model fit the data best, χ²(360)=905.82, p<.01, CFI=.94,
RMSEA =.051 (see Table 1). Factor loadings ranged from .53 to .85 and coefficient
alphas ranged from .69 to .88. Table 2 shows the fit indices for the models that were
evaluated. The null model supports 30 independent variables and no latent factors. The
ten-factor model specifies 10 correlated latent factors each with three items loading on
them. Finally, the two higher order factor model was a hierarchical model, which
specified two, correlated factors, representing experiential and behavioral POC
respectively, each with five latent POC variables loading on them and respective items
loading on the latent POC variables (see Figure 1 in the appendix).
External validation
POC and Stage of Change. Multivariate Analysis of Variance (MANOVA)
found a significant main effect for Stage of Change (Wilk’s Λ=.72, F(40, 2201.1) =
4.89, multivariate η2= .08). This indicates that use of the POC subscales differed
significantly by Stage of Change. Follow-up ANOVA values are as follows:
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Consciousness Raising F(4, 589) = 13.03, p<.01, η2= .08; Dramatic Relief F(4, 589) =
5.89, p<.01, η2= .04; Environmental Reevaluation F(4, 589) = 8.26, p<.01, η2= .05;
Self-Reevaluation F(4, 589) = 18.81, p<.01, η2= .11; Social Liberation F(4, 589)
19.23, p<.01, η2= .12; Self-liberation F(4, 589) = 26.83, p<.01, η2= .15; Reinforcement
management F(4, 589) = 21.21, p<.01, η2= .13; Helping relationships F(4, 589) =
8.80, p<.01, η2= .06; Counterconditioning F(4, 589) = 30.09, p<.01, η2= .17; and
Stimulus Control F(4, 589) = 29.98, p<.01, η2= .17. Figures 1 and 2 show the
experiential and behavioral POC comparisons by stage respectively.
Table 3 shows the results of post-hoc tests evaluating which stages showed
significant differences for each POC subscale. Findings showed that individuals in
Precontemplation used experiential POC less than individuals in all other stages with
the exception of Consciousness Raising and Social Liberation. Results showed that
individuals in Precontemplation, Contemplation and Preparation used behavioral POC
less (with the exception of Helping Relationships) than those in Action and
Maintenance. All three exceptions to the patterns specified above were differences
between individuals in Contemplation and other stages, which may have been a
function of the small sample size of participants in Contemplation.
POC, Decisional Balance and Self-efficacy. Experiential POC and behavioral
POC were summed and two higher order constructs were created in order to evaluate
the relationships between POC, Decisional Balance and Self-efficacy. Correlations
among the POC factors (experiential and behavioral), Decisional Balance (Pros and
Cons), and Self-efficacy were then evaluated. Experiential POC and behavioral POC
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were significantly positively correlated with one another as well as with Pros, Cons
and Self-efficacy (Table 4).
DISCUSSION
The primary goal of this study was to develop a psychometrically and
conceptually sound measure of TTM Processes of Change relevant for reducing
anxiety-based avoidance. To our knowledge, this is the first study to apply the TTM
Processes of Change to anxiety. Items had strong content and face validity per expert
interviews and qualitative interviews with participants. Confirmatory factor analyses
performed on the final set of items supported a correlated, ten-factor model structure,
which has been observed in POC measures for a number of other behaviors (Amoyal
et al., 2013; Fernandez et al., 2013; Marcus et al., 1992). Items demonstrated strong
loadings on factors (ranging from .53 to .85), and POC subscales for the final
measures showed good internal consistency (alphas ranged from good .88 for Helping
Relationships to acceptable .69 for Environmental Reevaluation; Costello & Osborne,
2005).
This study adds to a base of literature that has compared fit indices between
alternative factor structures for the POC. In one hypothesized factor structure, the five
experiential and behavioral POCs each load on one of two correlated higher order
factors, one representing the experiential POC and the other representing the
behavioral POC (see Figure C1 in appendix). The alternative factor structure tested
was a 10-factor, fully correlated model. In this study, the 10-factor correlated model
was a better fit to the data. Taken together with previous findings that support the 10factor, correlated model over the two higher order factor model (Amoyal et al., 2013;
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Fernandez et al., 2013; Beth H Marcus et al., 1992), these results raise the question of
whether the division of POCs into two groups (experiential and behavioral) is more
conceptually- than data-driven. Further evaluation of the factor structure that best fits
data in different areas of behavior change is needed to determine the empirical
distinction between experiential and behavioral POCs.
Similar to studies of POC measures for other behaviors, our findings indicated
reliable differences in POC use across Stage of Change. Overall experiential POC use
showed the biggest differences between Precontemplation and Contemplation,
whereas behavioral POC showed the biggest differences between Preparation and
Action. Some experiential POC, namely Dramatic Relief and Environmental
Reevaluation, showed flattening after Contemplation, which indicates that intervening
to increase use of these processes may be most important in early stages. Additionally,
participants in all pre-Action stages use most behavioral POC significantly less than
participants in Action/Maintenance. In contrast, significant differences in experiential
POC use were mainly between Precontemplation and all other stages. This finding
supports a distinction between experiential and behavioral POCs insofar as they
appear to be used most frequently in different stages of the change process. Another
pattern observed that is consistent with previous literature and supports the external
validity of this measure was that Precontemplators reported using POCs significantly
less frequently than individuals in Action and Maintenance for all POCs (Prochaska &
DiClemente, 1983).
Cross-stage effect sizes were mostly in the small to medium range. As has
been observed in some other areas of behavior change, effect sizes were consistently
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larger for behavioral POCs than experiential POCs (Marcus et al., 1992). Among
experiential POCs, Self-reevaluation and Social Liberation showed the largest effect
sizes. Among the behavioral POC, Counterconditioning and Stimulus Control showed
the largest effect sizes. Differences in effect size provide insight into which POC may
be most useful to intervene on at different levels of readiness.
Relationships between POCs and other TTM constructs were evaluated as a
means of external validation. The expectation is that as Decisional Balance and Selfefficacy shift in favor of change, POC will be used more frequently. As hypothesized,
experiential and behavioral POCs were positively correlated with the perceived
importance of Pros of reducing avoidance as well as with Self-efficacy (that one could
maintain a commitment to approaching feared stimuli across a range of challenging
situations). This study found a significant positive correlation between POC and
perceived importance of Cons of change, a result that has also been found for some
other behaviors (e.g., Amoyal et al., 2013). One interpretation of this finding is that
Cons do not deter participation in change-related cognitive and behavioral activities
and may be keenly experienced throughout the change process.
A few correlations between TTM variables were particularly high and,
therefore, warrant additional discussion. Namely, Pros were most highly correlated
with experiential POC, and Self-efficacy was most highly correlated with behavioral
POC. These correlations may be owing to the relative importance of Pros and
experiential POC in earlier stages and the relative importance of Self-efficacy and
behavioral POC in the later stages. However, further exploration of potential causal
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relationships between these variables (e.g., perception of the importance of Pros
producing more frequent of engagement in experiential POC) would be worthwhile.
Several limitations of this study should be acknowledged. First, this study
utilized a cross-sectional design. Longitudinal studies will be necessary to evaluate the
degree to which increasing POC use drives change and to enhance applicability of
findings to intervention development. Second, the participant sample was
predominantly white and non-Hispanic, which may limit the generalizability of
findings to minority populations. Although factor structures and validity findings for
TTM constructs have often generalized well to minority samples, the applicability of
this scale to more diverse populations must be evaluated (Blaney et al., 2012).
Additionally, the sample consisted of individuals who agreed to be part of a large
survey-sampling company’s national database, which may have produced selfselection bias. Finally, approximately half of our sample was in the Action or
Maintenance Stage of Change. While stage by POC analyses were weighted for
differing stage samples sizes, these sample characteristics may have affected the
measurement development process. Also the particularly small sample size for
individuals in Contemplation, is likely why comparisons between the use of POCs in
the Contemplation and other stages were often not significant even when fairly large
differences were observed. Future research evaluating findings with a more diverse
sample, more equal stage distribution (or even a pre-Action only sample), and
proactive recruitment that reaches out to a full population, rather than just those who
sought out opportunities to participate in online surveys, is warranted.

79

The results of the present study have important theoretical and applied
implications for treatment of anxiety disorders. Interventions for anxiety disorders
need to be designed to treat both individuals who are ready to reduce their avoidance
and individuals who are suffering from anxiety, but not ready to take the steps
required to address it. This study developed a measure of ten strategies used to
facilitate motivation and engagement in behavior change that can help guide clinicians
and researchers in tailoring interventions to patients’ level of readiness.
This measure can be used in the context of therapy and treatment research to
evaluate the cognitive, behavioral, and emotional activities a patient or participant is
engaging in and facilitate a more readiness-tailored intervention. Additionally, there is
a strong precedent for using the TTM as a framework for developing computer-based
interventions that can be used as an adjunct to in-person treatments or alone for those
who do not have access to or are unwilling to seek in-person treatment. Such
interventions involve administering a POC measure and providing feedback tailored to
an individual’s score on the instrument as well as Stage of Change. These
interventions are low-cost, accessible, and have been found to be effective in
producing behavior change relevant for other mental health disorders (e.g., Levesque
et al., 2011). Integration of stage-matched POC feedback into existing and new
interventions has the potential to allow the field to take a more population-based
approach that could help solve the knowledge-dissemination gap plaguing treatment of
anxiety disorders.
CONCLUSIONS
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This study developed a reliable (internally consistent) and valid instrument for
measuring TTM Processes of Change for reducing anxiety-based avoidance in anxious
individuals. Findings also support the applicability of the TTM to anxiety-based
avoidance insofar as the measurement structure and relationship between TTM
constructs adhered to models observed in other behaviors. This POC instrument is
appropriate for use in clinical settings and treatment research to design and implement
readiness-matched interventions. It could also be used to develop a cost-effective,
easy-to-access, TTM-based computer-tailored intervention, which has potential to
have a large impact on the population of individuals with anxiety disorders who are
not in treatment.
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Table 1.
Item Loadings from Confirmatory Factor Analysis and Coefficient Alpha’s for
Experiential and Behavioral Processes of Change.
Factor
Loadings

Processes of Change
Experiential Processes
Consciousness Raising (α=.80)
I search the internet for information on how to better manage my anxiety.
I pay attention to information from the tv, radio, and articles on how to manage
my anxiety.
I Google the effects of anxiety on my health and functioning.

0.85
0.70
0.75

Dramatic Relief (α=.73)
I am disappointed when I notice that I missed or avoided something because of
my anxiety.
I feel sad when I see how anxiety affects my life.
I feel frustrated when I compare myself to others who have less anxiety.

0.63
0.76
0.69

Environmental Reevaluation (α=.69)
I consider that avoiding things because of my anxiety may make me a worse role
model.
I pay attention to how my anxiety affects my family.
I think that managing my anxiety may prevent me from being a burden on others.

0.53
0.70
0.74

Self-reevaluation (α=.71)
I imagine a day when anxiety has less control over my life.
I think that addressing my anxiety would make me feel like a more confident
person.
I feel more like the person I want to be when I take steps to manage my anxiety.

0.59
0.69
0.74

Social Liberation (α=.83)
I see that more and more people are getting help dealing with their anxiety.
I notice more opportunities to get support in managing my anxiety.
I notice the media are more open to covering people’s struggles with anxiety.

0.76
0.83
0.76

Behavioral Processes
Self-liberation (α=.80)
I believe I can carry through with my goal to do some of the things that make me
anxious.
I renew my commitment to face my fears one step at a time.
I tell myself that I can approach things that make me anxious if I work at it.

0.71
0.77
0.78

Reinforcement Management (α=.83)
I give myself credit for the hard work I’m doing to manage my anxiety.
I do something nice to reward myself when I don’t give into the urge to avoid.
As I approach more things over time, if feels good to see that I’m becoming less
anxious.

0.80
0.79
0.78

Helping Relationships (α=.88)
I am supported by others in my efforts to stop avoiding things that make me
anxious.
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0.83

Friends or relative let me know they are there to help me manage my anxiety.
I see that I have someone who encourages me to manage my anxiety.

0.84
0.85

Counter Conditioning (α=.81)
When I start feeling anxious, I take time to practice mindfulness or to practice
focusing on the
present moment.
When I start having anxious thoughts, I practice challenging them.
I practice doing things that make me anxious, rather than avoiding them.

0.71
0.78
0.81

Stimulus Control (α=.81)
I organize my schedule in a way that requires me to face my fears.
I plan activities that encourage me to face the things that make me anxious.
I use my phone, computer or calendar to remind me to take steps to manage my
anxiety.
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0.79
0.81
0.72

Table 2.
Robust Estimation Method Fit Indices for Processes of Change Confirmatory Models
χ² (df)

CFI

RMSEA (CI)

Full null model

9268.90* (435)

--

Ten factor model

905.82* (360)

0.94

.051 (.046, .055)

Two higher order factor model

1334.40* (394)

0.89

.063 (.060, .067)

--

Note. N= 594; χ² = chi square; df = degrees of freedom; CFI = comparative fit index;
RMSEA = root mean square error of approximation; CI = confidence interval; *p<.01.
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Table 3.
Stage Group Comparisons on Each of the Processes of Change
Process
Consciousness raising
Dramatic relief
Environmental reevaluation
Self-reevaluation
Social Liberation
Self Liberation
Reinforcement management
Helping relationship
Counterconditioning
Stimulus control

Comparisons of stage-of-change groups
PC < PR/A/M
PC < All
PC < All
PC < All
PC < PR/A/M, PR<A/M
PC < PR/A/M, C < A/M, PR < A/M
PC < PR/A/M, C < A/M, PR < A/M
PC < A/M, PR < A/M
PC < PR/A/M, C < A/M, PR < A/M
PC < A/M, C < A/M, PR<A/M

Note. PC = Precontemplation; C = Contemplation; PR = Preparation; A = Action; M =
Maintenance; ALL = All other stages of change; p < .05, using Tukey tests.
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Table 4.
Correlations between Processes of Change and other TTM constructs

Experiential
Processes
Behavioral
Processes
Pros
Cons
Self-Efficacy

Behavioral
Processes
.659*

Pros
.546*

Cons
.270*

SelfEfficacy
.312*

--

.210*

.196*

.601*

--

.275*
--

.074
.045
--

Note. *p < 0.01 level (2-tailed).
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Figure 1.
Experiential Processes of Change by Stage

54
52

T-Score

50
CR

48

DR
ER

46

SR
SO

44
42
PC (n=84)

C (n=23) PR (n=123) A (n=101) M (n=263)
Stage

Note. PC = Precontemplation; C = Contemplation; PR = Preparation; A = Action; M =
Maintenance; CR = Consciousness Raising; DR = Dramatic Relief; ER =
Environmental Reevaluation; SR = Self-reevaluation; SO = Social Liberation.
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Figure 2. Behavioral Processes of Change by Stage

53
51

T-Score

49
SL

47

RM
HR

45

CC
SC

43
41
PC (n=84)

C (n=23) PR (n=123) A (n=101) M (n=263)
Stage

Note. PC = Precontemplation; C = Contemplation; PR = Preparation; A = Action; M
= Maintenance; SL = Self Liberation; RM = Reinforcement Management; HR =
Helping Relationships; CC = Counterconditioning; SC = Stimulus Control.
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APPENDIX A: SUPPLEMENTAL TABLE FOR MANUSCRIPT 1
Table A1.
2 x 2 Contingency Table for Reported Chi-Square Test

Stage

In Treatment
No

Yes

PreAction

38.3%
(88)

61.7%
(142)

AM

25.8%
(94)

74.2%
(270)

Note. Pre-Action = Precontemplation, Contemplation or Preparation; AM = Action or
Maintenance.
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APPENDIX B: SUPPLEMENTAL TABLE FOR MANUSCRIPT 2
Table B1.
Maximum Likelihood Method Fit Indices for Decisional Balance and Self-Efficacy Confirmatory Models
χ²(df)

CFI

GFI

RMSEA (CI)

Model 1: null model

1113.78 (45)*

--

Model 2: uncorrelated two factor model

112.94 (35)*

.927

.930

.086 (.068, .103)

Model 3: correlated two factor model

96.48 (34)*

.942

.938

.078 (.060, .096)

862.67 (15) *

--

37.82(9)*

.973

Decisional Balance
--
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Self-efficacy
Model 1: null model
Model 2: one factor model

-.957

.103 (.070, .137)

Note. N = 305; χ² = chi square; df = degrees of freedom; CFI = comparative fit index; GFI = Goodness of fit index; RMSEA = root
mean square error or approximation; CI = confidence interval; *p<0.01
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APPENDIX C: SUPPLEMENTAL TABLES AND FIGURES FOR MANUSCRIPT 3
Table C1.
Maximum Likelihood Method Fit Indices for Processes of Change Confirmatory
Models
χ² (df)

CFI

RMSEA (CI)
--

Full null model

11017.91 (435)

--

Ten factor model

1251.74 (360)

0.92

.065 (.061, .068)

Two higher order factor model

1802.76 (394)

0.87

.078 (.074, .081)

Note. N= 594; χ² = chi square; df = degrees of freedom; CFI = comparative fit index;
RMSEA = root mean square error of approximation; CI = confidence interval; *p<.01.
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Table C2.
Correlations Between Processes of Change
CR
--

DR
.33
--

ER
.39
.61
--

SR
.42
.53
.56
--

SO
.62
.23
.39
.56
--
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SL
CR
.48
DR
.18
ER
.38
SR
.59
SO
.63
CC
.80
SC
.71
HR
.56
RM
.75
SL
-Note. CR = Consciousness Raising; DR = Dramatic Relief; ER = Environmental Reevaluation; SR = Self-reevaluation; SO = Social
Liberation; CC = Counterconditioning; SC = Stimulus Control; HR = Helping Relationships; RM = Reinforcement Management; SL
= Self Liberation.

103

CC
.53
.17
.37
.53
.65
--

SC
.59
.13
.30
.41
.60
.78
--

HR
.42
.15
.35
.41
.58
.57
.58
--

RM
.55
.19
.33
.54
.66
.79
.78
.63
--

Figure C1. Two Higher Order Factor Model Diagram

Note. The above diagram illustrates the alternative to the 10-factor fully correlated
model. In the 10-factor fully correlated model, all POC latent variables were
correlated. In this model only the disturbances of the two higher order factors were
correlated (marked by the two way arrow).
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APPENDIX D: TTM CONSRUCTS ACROSS TREATMENT STATUS GROUPS
As specified in the above chapters, data was collected on participants’ current
treatment status. Participants were asked to select one of four mutually exclusive
categories: (a) I am NOT currently in treatment for anxiety; (b) I currently take
medication for anxiety (prescribed by a health professional like a doctor, nurse or
psychiatrist); (c) I currently go to therapy or counseling for anxiety (meeting for 30
minutes to an hour to discuss your feelings with a professional); (d) I currently take
medication and go to therapy for anxiety.
ANOVAs were conducted to evaluate differences in scores on the OASIS and
continuous TTM constructs (Pros, Cons, Self-efficacy, behavioral Processes of
Change and experiential Processes of Change) across treatment status group. A chisquare test was conducted to evaluate the association between Stage of Change and
treatment status group.
Descriptive statistics are summarized in Table D1, ANOVA results are
summarized in Table D2 below, and the distribution of stage within each treatment
status group is displayed in Figure D1. A significant difference in level of anxiety
across treatment status group was observed (F (3, 590) = 13.52, p<.01, η2=.06). Post
hoc comparisons using the Tukey HSD test indicated that the mean OASIS score of
participants in combined medication and therapy treatment (M = 13.93, SD = 3.50)
was significantly higher than that of participants taking medication only (M = 11.69,
SD = 2.95), in therapy only (M = 12.39, SD = 2.89) and even those not in treatment at
all (M = 12.02, SD = 3.00). ANOVA also indicated a significant difference in reported
frequency of behavioral Process of Change use across treatment status group (F(3,
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590) = 4.31, p < .01, η2=.02). Post hoc comparisons using the Tukey HSD test showed
that the mean behavioral Process of Change score for those in psychotherapy only (M
= 46.17, SD = 11.44) was significantly higher than for those not in any treatment (M =
39.37, SD = 14.59). No other significant group differences were observed. Finally, a
chi-square test indicated that there was a significant association between stage and
treatment status group, χ² (12, n= 594) = 25.25, p=.014, phi=.21.
The finding that individuals in combined treatment showed the highest level of
anxiety is counterintuitive, but consistent with existing literature that indicates that
individuals with higher levels of anxiety tend to seek more treatment than those with
lower levels of anxiety (Weisberg, Dyck, Culpepper, & Keller, 2007).
Findings of differences in scores on TTM constructs across treatment status
groups warrant some discussion. One possible interpretation of the observed
difference in behavioral Process of Change use is that behavioral Processes of Change
are encouraged in psychotherapy. Medication, while it may reduce symptoms
equivalently to psychotherapy, does not entail discussion and problem solving around
behavior change. The group of individuals engaging in psychotherapy and medication
reported the most severe symptoms in terms of the OASIS and, therefore, may not
have been willing to engage in as many behavioral Processes of Change. It is also
interesting that no other significant differences in TTM variable use across treatment
status groups were observed. In particular, we would have expected to see similar
differences in experiential Processes of Change. Reported frequency of experiential
Process of Change use, however, was high across all treatment status groups. The
range of mean scores for experiential Processes of Change was 47.62 to 50.57 whereas
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the range of mean scores for behavioral Processes of Change was 39.37 to 46.17.
Additionally, while not statistically significant, a similar pattern was observed in
experiential Process of Change use with those in no treatment reporting the lowest
level of use and those in psychotherapy only reporting the highest level of use. One
interpretation of this finding is that experiential Processes of Change around reducing
avoidance are things that anxious individuals experience naturally (i.e., with or
without treatment). With regard to other TTM constructs, differences between
treatment status group mean scores on Pros, Cons and Self-efficacy were small in
magnitude, which may indicate that more could be done by treatment providers to
attend to and modify motivational variables.
Finally, Stage of Change within each treatment status group showed expected
patterns. Of particular note, was the similarity between the stage profile of those
taking medication only versus those in psychotherapy only. The main descriptive
distinction between these two groups was that a higher percentage of those in
medication only were in Precontemplation than those in therapy only and a higher
percentage of those in psychotherapy only were in Action. This supports the view that
it is easier to take medication while not intending to change avoidance patterns than to
be in psychotherapy while not be intending to change avoidance patterns, since
medication is by definition a more passive approach to addressing anxiety. Another
difference of note is the similarity in stage distribution between those not in treatment
and those in combined treatment. One possible interpretation of this finding is that
more treatment is not necessarily better in terms of readiness to reduce approach
behaviors, however this finding may be complicated by the higher level of anxiety
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observed for those in combined treatment.
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Table D1.
Descriptive Statistics for OASIS and TTM Variables by Treatment Status Group

OASIS
Pros
Cons
Self-efficacy
Exp POC
Beh POC

No
Medication
Treatment
(n=256)
(n=182)
12.02 (3.00)
11.67 (2.95)
20.32 (3.97)
20.12 (4.05)
15.68 (4.29)
15.77 (4.21)
14.85 (4.96)
15.08 (5.13)
47.62 (11.33) 47.69 (11.23)
39.37 (14.59) 42.23 (12.56)

Psychotherapy
(n=54)
12.39 (2.89)
19.78 (3.93)
16.57 (4.03)
15.80 (5.23)
50.57 (10.41)
46.17 (11.44)

Combined
(n=102)
13.93 (3.50)
20.99 (3.65)
16.66 (4.64)
14.24 (5.69)
49.17 (9.02)
40.84 (11.74)

Note. Table presents mean scores with standard deviations in parentheses. OASIS =
Overall Anxiety Severity and Impairment Scale; Exp POC = Experiential Processes of
Change; Beh POC = Behavioral Processes of Change; Medication = taking medication
but not psychotherapy for anxiety; Psychotherapy = in psychotherapy but not taking
medication for anxiety; Combined = taking medication and in psychotherapy for
anxiety.
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Table D2.
ANOVAS for OASIS and TTM Variables by Treatment Status Group
DV
OASIS
Pros
Cons
Self-efficacy
Exp POC
Beh POC

F

P

2

13.52*
1.52
1.70
1.20
1.50
4.31*

0.00
0.21
0.17
.31
0.21
0.01

0.064
0.008
0.009
0.006
0.008
0.021

Note. Between group degrees of freedom for all analyses = 3; Within group degrees of
freedom for all analyses = 590; OASIS = Overall Anxiety Severity and Impairment
Scale; Exp POC = Experiential Processes of Change; Beh POC = Behavioral Process
of Change; df = between group degrees of freedom, within group degrees of freedom;
*p<.05.
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Figure D1.
Percentage of Participants in each Stage of Change within Each Treatment Status
Group
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Note. Medication = taking medication but not psychotherapy for anxiety;
Psychotherapy = in psychotherapy but not taking medication for anxiety; Combined =
taking medication and in psychotherapy for anxiety; PC = Precontemplation; C =
Contemplation; PR = Preparation; A = Action; M = Maintenance.
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APPENDIX E: DESCRIPTIVE DATA ON REASONS PARTICIPANTS
ENDORSED FOR NOT SEEKING TREATMENT FOR ANXIETY
Part of improving the reach of evidence-based treatments for anxiety is
evaluating why many individuals with clinically significant anxiety are not in
treatment. Access is one important factor that limits reach, but perceived need and
other intra-individual factors have also been found to be key reasons individuals do
not seek treatment (Kivelitz, Watzke, Schulz, Harter, & Melchior, in press; Mojtabai
et al., 2011; Weisberg et al., 2007). This literature builds a case for the importance of
interventions and outreach programs that attend to both access and intra-individual
variables.
This study sought to examine possible barriers to treatment-seeking by
providing those not taking medication and/or in psychotherapy for anxiety with a
checklist of possible reasons for not seeking these treatments. The checklist used was
adapted from Weisberg et al. (2007). Table E1 presents the frequency with which
reasons for not taking medication and for not being in psychotherapy were endorsed.
The most frequent reasons endorsed for not taking medication were concern
about side effects (52.1%) and the cost of medication (36.4%). The most frequent
reasons for not engaging in therapy for anxiety were cost (50.0%) and having found
therapy ineffective in the past (28.1%). Consistent with these findings, financial
concerns have previously been found to be a prominent reason individuals do not seek
treatment, especially psychotherapy (Kessler et al., 2001; Mojtabai, Olfson, &
Mechanic, 2002; Weisberg et al., 2007). Taken together with previous research, these
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findings indicate that cost-effective, evidence-based behavioral interventions have
huge potential for reducing impediments to care.
Interestingly, the least frequent reason endorsed for not taking medication and
for not seeking therapy was not thinking one had a problem. These findings pose a
sharp contrast to previous research indicating that low perceived need for treatment is
a leading reason why many people with clinically significant symptoms do not seek
mental health treatment. For example, Weisberg et al. (2007) found that in patients
with anxiety disorders, not thinking they had a problem and not believing in treatment
for emotional problems were two of the more frequently endorsed reasons for not
taking medication and for not engaging in psychotherapy. Broader research on reasons
individuals with mental illness choose not to seek treatment also support not
recognizing that one has a problem or wanting to solve the problem on their own, as
prominent factors that distinguish those who seek treatment from those who do not
(Blumenthal & Endicott, 1998; Kessler et al., 2001; Mojtabai et al., 2011). One
possible explanation of findings from the present study is that participants in this
survey were part of a group of individuals interested in participating in health-related
surveys. It may be that this group is more informed about and open to addressing
health-related issues. Other studies cited above used proactive recruitment methods,
which may better capture the full population of individuals with anxiety disorders.
Nevertheless, this discrepancy in findings calls for further investigation of the degree
to which individuals with anxiety perceive a need for treatment.

113

Table E1.
Reasons Endorsed for not Receiving Medication (n=236) and Psychotherapy (n=438) for Anxiety
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didn’t know how to obtain
financial reasons
worried about sigma/embarrassment
inconvenient/too busy
ineffective in the past
Concerned about side effects
Didn’t think s/he had a problem
Didn’t believe in medication/therapy
for emotional problems
Not recommended by doctor
Didn’t think it would help
Concerned about having mental health
treatment on record

Reasons for not Receiving Medication
14.8% (n=35)
36.4% (n=86)
10.6% (n=25)
4.2% (n=10)
17.8% (n=42)
52.1% (n=123)
2.5% (n=6)
14.4% (n=34)

Reasons for not Receiving Psychotherapy
14.6% (n=64)
50.0% (n=219)
15.8% (n=69)
19.9% (n=87)
28.1% (n=123)
-2.3% (n=10)
3.4% (n=15)

8.1% (n=19)
16.5% (n=39)
5.9% (n=14)

10.3% (n=45)
19.2% (n=84)
7.5% (n=33)

Note. Responses provided above were not mutually exclusive. That is, participants could select any options that applied to them.
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APPENDIX F: CROSS-RACIAL COMPARISONS OF STAGE OF CHANGE AND
MEAN SCORES ON TTM CONSTRUCTS
Minority groups are less likely to receive appropriate treatment than
mainstream populations (U.S. Department of Health and Human Services, 2001). One
overarching goal of the present program of research is to develop interventions that
would be accessible to underprivileged groups who are not currently receiving
appropriate services.
Based on U.S. Census data, racial minorities constitute approximately 28% of
the population in the United States (approximately 13% Black/African American, 5%
Asian, and 1% American Indian/Alaska Native, <1% Native Hawaiian/Other Pacific
Islander, 9% Other/Mixed race). 2010 U.S. Census data indicate that approximately
16% of the U.S. population is Hispanic or Latino. The racial distribution of the sample
in this study approximated US census data. In this sample, 23.6% (n=140) identified
as a racial minority (12.8% Black/African American, 3.7% Asian, 1.2% American
Indian/Alaska Native, 0.2% Native Hawaiian/Other Pacific Islander, 5.7%
Other/Mixed race). Additionally, 14.8% of this sample identified as Hispanic or
Latino.
In this early, measurement development, phase of this program of research,
cross-racial differences were not a focus. Nevertheless, preliminary evaluations of
differences in TTM constructs and treatment seeking between minority participants
and non-minority participants were conducted to begin exploring important racial
factors that may affect measurement and, ultimately, intervention.
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ANOVA showed significant differences in Cons, Self-efficacy, experiential
Processes of Change and behavioral Processes of Change between minority and nonminority participants (Table F1). All differences were in the direction of minority
participants scoring higher (i.e., greater perceived importance of Cons, higher Selfefficacy and more frequent use of behavioral and experiential Processes of Change).
A chi-square test supported association between race and Stage of Change, χ²
(4, n= 594) = 14.78, p<.01, phi=.16. Descriptive evaluations of percentages of
minority and nonminority participants in each Stage of Change are displayed in Figure
F1. The pattern of stage distribution by minority status indicates that the significant
chi-square may be attributed to the greater percentage of minority participants in
Action and Maintenance compared to white participants and the greater percentage of
white participants in Precontemplation and Preparation compared to minority
participants.
A chi-square test did not support an association between race and treatment
seeking in general, χ² (1, n= 594) = 0.05, p=.82, phi=-.01. However, an additional chisquare test that involved dividing treatment seeking into categories (no treatment,
medication only, therapy only, and combined) did support an association between race
and type of treatment χ² (3, n= 594) = 17.97, p<.01, phi=.17. As shown in Figure F2,
this finding is likely attributable to two trends. First, the percentage of white
participants taking medication only was higher than the percentage of minority
participants taking medication only. Second, the percentage of minority participants in
psychotherapy only or combined (psychotherapy and medication) treatment was
greater than the percentage of white participants in these treatment categories.
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These findings indicate that racial differences in use of TTM constructs needs
to be studied further. Findings may be an artifact of the specific and small sample of
minority participants recruited in this study. In particular, this study recruited minority
participants who were part of a national survey company’s database of individuals
interested in survey research. It is not clear whether this segment of the population in
is representative of the entire population of individuals with clinically significant
levels of anxiety for either minorities or non-minorities. Nevertheless, if differences
hold up in future studies, tailoring algorithms that differ by race (e.g., higher cutoffs
for tailored feedback) may be important.
The finding that there was no difference in rates of treatment-seeking between
minority and non-minority participants is not consistent with predictions based on
existing literature. Previous research indicates that individuals from minority groups
are less likely to receive treatment and more likely to report feeling uncomfortable
talking to a professional about personal problems than non-minorities (Shim,
Compton, Rust, Druss, & Kaslow, 2009). In contrast to existing research, this study
evaluated whether treatment was sought and the type of treatment sought rather than
attitudes toward treatment, which may be a reason findings do not seem to match other
research to date. Also, again, it is possible that present findings are a result of potential
sampling bias in the present study driven by use of a survey sampling company for
recruitment. Nevertheless, further investigation of the nuances of potential differences
in treatment-seeking across racial categories will be an important area for future
research.
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Table F1.
ANOVAS Comparing OASIS and TTM Variables Between White and Minority
Participants
DV
OASIS
Pros
Cons
Self-efficacy
Exp POC
Beh POC

White
(n=454)
M (SD)
12.13 (3.16)
20.39 (3.88)
15.72 (4.23)
14.56 (4.91)
47.59 (10.53)
40.25 (12.60)

Minority
(n=140)
M (SD)
12.56 (3.13)
20.02 (4.20)
16.77 (4.46)
16.14 (5.88)
50.10 (11.69)
45.45 (13.92)

F

p

2

1.95
0.94
6.50*
10.05*
5.76*
17.34*

0.16
0.33
0.01
<.01
0.02
<.01

<0.01
<0.00
0.01
0.02
0.01
0.03

Note. between group degrees of freedom for all analyses =1; within group degrees of
freedom for all analyses = 592; OASIS = Overall Anxiety Severity and Impairment
Scale; Exp POC = Experiential Processes of Change; Beh POC = Behavioral Process
of Change; *p<.05.
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Figure F1.
Percentage of White and Minority Participants in Each Stage of Change
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Note. PC = Precontemplation; C = Contemplation; PR = Preparation; A = Action; M =
Maintenance.
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Figure F2.
Percentage of White and Minority Participants in Each Treatment Status Group
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Note. Medication = taking medication but not psychotherapy for anxiety;
Psychotherapy = in psychotherapy but not medication for anxiety; Combined = taking
medication and in psychotherapy for anxiety.
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APPENDIX G: CROSS-GENDER COMPARISONS OF STAGE OF CHANGE AND
MEAN SCORES ON TTM CONSTRUCTS
Anxiety disorders have been found to be more prevalent in woman then in men
(Bruce et al., 2005). For example the National Comorbidity survey found that the
lifetime prevalence of any anxiety disorders was 30.5% in women and 19.2% in men
(Kessler et al., 2005). Given these prevalence rates, it is not surprising that the sample
recruited for this study included more women (69.4%, n = 412) than men (30.6%,
n=182). In this early, measurement development, phase of this program of research,
gender differences were not a focus. Nevertheless, investigation of differences in
scores on TTM constructs and treatment-seeking between male and female
participants were conducted to begin to examine whether gender differences may
impact measurement and, ultimately, intervention.
ANOVA showed a significant difference in perceived importance of the Pros
with women rating perceived importance as significantly higher than men (see Table
G1). ANOVA also indicated that men reported greater Self-efficacy (that they could
engage in approach behaviors even in challenging situations) than women (see Table
G1). It should be noted, that effect sizes of both of these differences were small, so,
while they are statistically significant, the practical or clinical implications may be
limited.
A chi-square test did not support an association between gender and Stage of
Change, χ² (4, n= 594) = 3.98, p=.41, phi=.08. Similarly, a chi-square test did not
support an association between gender and treatment status group, χ² (3, n= 594) =
7.21, p=.065, phi=.11.
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These findings indicate limited differences across gender. The majority of
variables evaluated did not show cross-gender differences. Differences that were
observed had small effect sizes. These results do not, therefore, necessarily indicate
that different tailoring cutoffs or strategies should be used for males and females.
Nevertheless, future research with different recruitment methods and longitudinal data
should continue to evaluate the potential for differences in TTM construct use across
gender.
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Table G1.
ANOVAS Comparing OASIS and TTM Variables Between Male and Female
Participants
DV
OASIS
Pros
Cons
Self-efficacy
Exp POC
Beh POC

Male
(n=182)
M (SD)
12.37 (3.15)
19.63 (4.02)
16.46 (4.35)
15.84 (5.60)
47.33 (10.90)
41.91 (12.46)

Female
(n=412)
M (SD)
12.18 (3.16)
20.60 (3.89)
15.75 (4.27)
14.53 (4.95)
48.56 (10.83)
41.28 (13.39)

F

p

2

0.48
7.81*
3.44
8.19*
1.63
0.29

0.49
<0.01
0.06
<.01
0.20
0.59

<0.01
0.01
<0.01
0.01
<0.01
<0.01

Note. between group degrees of freedom for all analyses =1; within group degrees of
freedom for all analyses = 592; M = mean; SD = standard deviation; OASIS = Overall
Anxiety Severity and Impairment Scale; Exp POC = experiential Processes of Change;
Beh POC = behavioral Process of Change; *p<.05.
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